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Prenatal exposure to various stressors can influence both early and later childhood health. 
Microbial infection of the intrauterine environment, and specifically within the placenta, has 
been associated with deleterious pregnancy outcomes, such as preterm birth. Children that are 
born prematurely experience a higher rate of developmental problems throughout their lives, 
including neurocognitive impairment which persists into school-age and manifests as poor 
performance in school. The relationships among microorganisms in the placenta, placental 
function and fetal development are not well understood. Microorganisms have been associated 
with epigenetic modifications in other tissue types and are known to trigger an inflammatory 
response. Inflammatory proteins can damage the developing fetal brain.  
This goal of this research was to explore microorganisms in preterm placentas, their 
association with inflammation and DNA methylation, as well as later-life neurocognitive 
function. Using data from the Extremely Low Gestational Age Newborn (ELGAN) cohort we 
assessed the relationship between 15 microorganisms and three outcomes: (1) neurocognitive 
and social-communicative outcomes at age 10, (2) genome-wide DNA CpG methylation of the 
placenta, and (3) placental mRNA expression of inflammation-related genes.  Through these 
studies we demonstrated that different bacterial species have differential effects on the placenta 
and the child. The presence of certain microorganisms in the placenta were associated with 
neurocognitive delays at age 10. In contrast, the presence of Lactobacillus sp. was associated 
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with a lower risk of impaired neurocognitive functions. In the placenta, we found that the 
presence of bacteria led to differential methylation of 1,789 CpG sites, corresponding to 1,079 
genes. The altered genes encode for proteins that are involved in immune/inflammatory 
responses, specifically the NF-κB signaling pathway. Through evaluation of mRNA expression, 
we discovered that in the presence of certain bacteria there was an upregulation of inflammation-
related genes. Taken together, these findings increase the understanding of mechanisms by which 
microbial presence in the placenta contributes to the outcomes of the children later in life.  
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INTRODUCTION 
 The developmental origins of health and disease (DOHaD) hypothesis proposes that the 
prenatal environment, through fetal reprogramming, can influence adult disease and later-life 
outcomes [1, 2] including neurocognitive and mental health [3-5]. Epigenetic modifications are 
one proposed biological mechanism that controls early life programming of long-term health [6]. 
Supporting the DOHaD hypothesis, intrauterine infection and inflammation are associated with 
adverse birth outcomes, such as preterm birth (PTB), and neurodevelopmental outcomes later in 
life [5, 7-9]. Any attempt to understand the mechanisms underlying the association between 
prenatal exposures and adult disease must closely consider the placenta: a crucial organ at the 
interface of mother and fetus. The placenta also plays a critical role in the regulation of the 
intrauterine environment and providing the appropriate hormones necessary for fetal growth and 
development.   
 The presence of microorganisms in the human placenta and the potential of a placental 
microbiome is currently a contested topic, as the placenta has been considered a sterile organ [7]. 
However, a recent study suggests that the placenta harbors a unique microbiome [10].  This 
discovery could be due to a shift in the methods and technologies available for detecting bacteria. 
Traditional culture techniques focus on pathogenic organisms that are isolated, grown, and 
identified, a time-consuming process and one which can only detect those organisms amenable to 
culture [11]. However, new culture-independent techniques, including 16S ribosomal RNA 
(rRNA) gene sequencing, allow for the full microbiological biodiversity to be detected. 
Importantly, this method does not differentiate between living, dead or ruptured bacteria [12] but 
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can detect organisms of low-abundance [13],  as is typical in the placenta [10]. Since the 
presence of microorganisms in the placenta can lead to PTB and other deleterious birth outcomes 
[7, 14] it is relevant to identify and study these bacterial species and how they affect the placenta.  
In this review, we focus on the association between placental microorganisms and 
neurocognitive outcomes and examine potential biological mechanisms contributing to this 
association (Figure 1). There are well-established associations between intrauterine infection 
and inflammation [7, 15] and prenatal inflammation and neurodevelopment [16-20]. Here, we 
summarize evidence that bacteria in the placenta induce an inflammatory response through 
epigenetic modifications, specifically DNA methylation, that is associated with 
neurodevelopment and neurological functioning later in life.    
 
Figure 1. Schematic of the biological mechanisms underlying the association between 
placental microorganism and later life neurological outcomes. The arrows indicate the 
different associations that are discussed in the article. The presence of microorganisms in the 
placenta are associated with a) the production of inflammatory-proteins in placental cells [21, 
22]; b) a sustained systemic inflammatory response in newborns [23]; c) and the placental 
methylome [24]; d) the DNA methylation profile of the placenta has been associated with 
different neurodevelopmental outcomes in infants [25]; e) exposure to in utero inflammation 
leads to a greater risk of neurocognitive disorders [26, 27]. The presence of inflammatory 
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proteins in newborn blood has been associated with a variety of neurodevelopmental outcomes 
at; f) 2-years of age [28-31] and ; g) 10-years of age [32].  
 
i. Microorganisms in the Placenta 
 The presence of pathogenic bacteria in the placenta is associated with adverse birth 
outcomes,  including prematurity [7, 14], stillbirth [14, 33], and fetal inflammatory response 
syndrome [34, 35].  At one time the placenta and intrauterine environment were considered 
sterile and any bacterial presence was assumed to have originated from the lower genital tract 
[7]. Initially many of the bacteria identified in the uterus were of vaginal origin [36-38]. 
However, as techniques for identifying bacteria improved, species that were not part of the 
vaginal microflora were detected in the intrauterine environment, including the placenta. 
Recently, a metagenomics technique was used to characterize placental specimens and provided 
one of the first reports of a placental microbiome [10]. The studies demonstrated that the 
placenta harbors a microbiome that is of low-abundance but is metabolically rich and resembles 
the oral microbiome [10]. An association was also found between the placental microbiome and 
PTB [10]. This is of interest because many studies have documented the association between 
periodontal disease and PTB [39-43] and there is evidence that oral bacteria can translocate to 
the placenta [44]. However, the data on a placental microbiome are still contested, and more 
research is needed to confirm these findings [12, 45].  
Bacterial colonization of the human placenta not only occurs in preterm or at-risk 
pregnancies but also in the placentas of patients with normal, term pregnancies [10, 46]. The 
basal plate of 195 placentas have been analyzed for bacterial presence using staining methods 
[46]. A little over 25% of the placentas showed evidence of bacterial presence and no difference 
was found between preterm and term placentas [46]. These results suggest that there are 
potentially bacteria whose presence in the placenta exert no pathogenic effect and could even 
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promote normal development of the fetal immune system [47-50], whereas the presence of other 
microbes may activate an inflammatory response. Since this study used staining methods, 
bacterial species and their viability were not determined [46]. Conducting a deep sequencing 
analysis of the placentas of both term and preterm births could better characterize the placental 
microbiome, identify organisms of low prevalence, and determine which bacterial species may 
contribute to PTB [51]. 
Hematogenous transmission, or transmission through the bloodstream, is the leading 
explanation for how bacteria from the oral cavity colonize the placenta. Isolates of Enterococcus 
sp., Streptococcus sp., Staphylococcus sp., and Propionibacterium sp. have been isolated from 
umbilical cord blood, supporting the ability of these microorganisms to infect the bloodstream 
[52]. Hematogenous infection of Fusobacterium nucleatum, a bacterium present in the oral 
cavity, has been associated with colonization of the mouse placenta and was associated with 
preterm and stillbirth [53].  In fact a variety of oral bacteria have the ability to translocate to the 
placenta following hematogenous infection [44].  
Together these studies present evidence of  a placental microbiome that is similar to the 
oral microbiome [10, 46]. While the presence of microorganisms in the placenta is associated 
with  PTB, [10, 53]  microorganisms have been detected also in placentas from term pregnancies  
[46]. These observations indicate that there may be microorganisms that are commensal and 
nonpathogenic in the placenta. However, there is evidence that the presence of certain bacterial 
types or species can have deleterious effects on placental function and birth outcomes. 
.  
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ii. Placental Microorganisms and Inflammation 
Microorganisms in the placenta have been shown to induce an inflammatory response 
(Figure 1) that could trigger preterm labor and delivery [15]. Two studies have examined how 
trophoblasts, cells that form the outer layer of the blastocyst and develop into the placenta, 
respond to specific microorganisms. First, in cell culture, exposure of trophoblasts isolated from 
human placentas  to a variety of microorganisms  induced a release of interleukin (IL)-1, IL-6, 
IL-8, and IL-10, all of which are pro-inflammatory, except for IL-10 [21]. Separately, in a mouse 
model, placental trophoblasts were shown to play a role in the innate immune response to 
placental infection with Listeria monocytogenes and IL-12, IL-18, tumor necrosis factor (TNF)-
, and interferon- production increased following infection [22]. 
In order for inflammatory proteins to be produced, the initiating stimulus (e.g. 
microorganisms) must be identified by the host. Toll-like receptors (TLR) recognize molecules 
derived from microbes  and are important to the innate immune response, which includes  
inflammation [54]. The TLR signaling pathway triggers NF-B [55], which controls 
transcription  for IL-1, TNF-, and other pro-inflammatory cytokines [8].  Researchers have 
analyzed the human placenta for the presence and regulation of TLR2 and TLR4, specifically. 
TLR4 recognizes Gram-negative bacteria by its endotoxin lipopolysaccharide (LPS) [56, 57]. 
TLR2 recognizes a wide variety of pathogens including yeast [58], mycobacteria [59], and 
Gram-positive bacteria [60]. Placentas were analyzed from normal, term pregnancies and 
analyzed by immunohistochemical staining and found a presence of TLR2 and TLR4 in the 
trophoblasts of the placenta [61].   
Microbes in the placenta not only induce a localized inflammatory response but have also 
been associated with a sustained systemic inflammatory response in newborns (Figure 1). Using 
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527 placentas from the Extremely Low Gestational Age Newborn (ELGAN) study and newborn 
blood for microorganisms and inflammatory proteins, it was shown that newborns from whose 
placentas bacteria were recovered also had an increased expression of inflammatory proteins in 
their blood [23]. One exception to this was the presence of Lactobacillus sp. which was 
associated with a suppressed  inflammatory response [23]. This finding supports that not all 
microbes in the placenta are pro-inflammatory.  
Taken together, there is evidence that bacterial colonization of the placenta induces an 
inflammatory response that could potentially be sustained and impact birth outcomes and the 
long-term health of the infant. However, there are few studies that focus specifically on microbes 
in the placenta and an inflammatory response. One of these studies shows that the presence of 
bacteria in the fetal membranes does not always induce an inflammatory response [62]. The type 
of bacteria in the placenta could determine whether an inflammatory response is induced. TLR4 
is an active component of the inflammatory response in the placenta so Gram-negative bacteria 
could be of more consequence then other types of bacteria. Also, the expression of TLR4 could 
impact the magnitude of the inflammatory response.  response.  
iii. Microorganisms and DNA methylation 
Epigenetic mechanisms control gene expression but do not change base pair sequences 
[63]. There are different types of epigenetic modifications, including DNA methylation, histone 
modification, and microRNAs. DNA methylation is a process in which methyl groups are added 
to a base pair, specifically cytosine. The methyl group is added to DNA by the enzyme DNA 
methyltransferase (DNMT). Hypermethylation reflects an increase in methyl groups at a specific 
site while hypomethylation means a decrease in methyl group. Hypomethylation in promoter 
regions of DNA often leads to gene upregulation, with some exceptions [64].  
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Our current working hypothesis is that bacteria can lead to altered DNA methylation in a 
gene-specific or non-gene specific pattern (Figure 2). The presence of bacteria can induce the 
production of reactive oxygen species (ROS) by phagocytes [65] and ROS-induced oxidative 
stress has been shown to modulate DNA methylation that alters gene expression [66]. ROS can 
damage DNA and cause structural modifications through base modifications, base deletions and 
chromosomal breakages [67]. These structural modifications interfere with the activity of DNMT 
and lead to genome-wide, non-gene specific hypomethylation [66]. On the other hand, the 
transcription factor occupancy theory proposes that transcription factors are drivers of gene-
specific DNA methylation patterns [68]. The transcription factor binding to the DNA either 
prevents or allows the DNA methylation machinery access to the DNA sequences and therefore 
this binding influences gene-specific methylation. In this case the presence of bacteria induces an 
inflammatory response, therefore inflammation-related transcription factors are active, which 




Figure 2. Proposed mechanisms for non-gene specific and gene specific mechanisms of 
altered DNA methylation. Microbial presence may trigger the production of reactive oxygen 
species (ROS) and inflammation-associated transcription factors as a mechanism of cellular 
defense. ROS damages DNA which may render DNMT unable to access the DNA leading to 
genome-wide hypomethylation. On the other hand, transcription factors may bind to the DNA at 
specific inflammatory-related promoter regions. This binding may prevent or allow DNMT 
access to the DNA and leading to gene-specific differential methylation. 
 
Multiple studies have examined the presence of microorganisms in a variety of tissue 
types in relation to alterations of epigenetic mechanisms. The presence of E. coli in uroepithelial 
cells significantly increased the expression of DNMT and the promoter region of Cyclin 
Dependent Kinase Inhibitor 2A, a tumor suppressor, was hypermethylated while its expression 
was downregulated [69]. There is also evidence that the presence of Helicobacter pylori, which 
is associated with ulcers and stomach cancer, effects methylation patterns in the gastric mucosa. 
Eight sites that are known to be methylated in gastric cancer were found to be hypermethylated 
in the presence of H. pylori [70]. This is evidence that the presence of microorganisms can 
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influence the methylation state of DNA and alter epigenetic machinery, thereby contributing to 
disease. 
In examining the effects of bacteria on placental tissue methylation, a mouse model was 
used to determine the association between Campylobacter rectus and methylation of the Insulin 
Like Growth Factor 2 (IGF2) gene in the placenta. The promoter region of IGF2 was 
hypermethylated when C. rectus was present in the placenta [24]. IGF2 plays a critical role in 
placental growth as well as growth of the developing fetus [71]. In one of our recent studies we 
analyzed placental microorganisms in relation to genome-wide DNA methylation in the human 
placenta (Figure 1). Placentas in the ELGAN cohort were examined for the presence of 16 
different microbial species, of which 14 were associated with differential methylation of unique 
CpG probes. In total 1,789 probes were differentially methylated, corresponding to 1,080 genes. 
These genes were enriched for growth and transcription factors, the immune response, and the 
inflammatory response, specifically the NF-B pathway [72]. All of the probes associated with 
the genes were hypomethylated, which most likely leads to increased gene expression [72]. NF-
B has also been shown to increase with the onset of labour [73, 74] and also plays a role in 
inflammation-related disease [18].   This could be evidence that microorganisms in the placenta 
affect fetal development, birth outcomes, and later life disease through epigenetic changes in the 
placenta. However, in order to confirm this, it is necessary to examine gene expression of 
inflammatory-associated proteins in placental tissues in the presence of microorganisms. As 
discussed in the previous section this has been studied in cell culture and mouse model but not in 
the human placenta. 
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iv. Placental Methylome and Neurodevelopment 
Since the DOHaD hypothesis proposes epigenetic modifications as a mechanism by 
which prenatal exposures can contribute to later life disease [6], the placental methylome, as it 
relates to later life disease, including neurological function, has been of interest. Similarities have 
been shown between neuronal and placental DNA methylation profiles in genes that are 
associated with neuronal development [75], meaning DNA methylation in the placenta could 
contribute to neurodevelopment and neurocognitive outcomes later in life.  Multiple studies have 
examined the association between the DNA methylation patterns of specific genes in the 
placenta and neurological outcomes in infants, primarily using the NICU Network 
Neurobehavioral Scales (NNNS) (Figure 1). The NNNS evaluates neurologic measures, 
behavioral measures, and signs of stress in infants to determine neurobehavioral performance 
[76]. In addition to  its value  as an early-life assessment, the NNNS is predictive of 
neurodevelopmental and cognitive performance as well as school readiness in children [77, 78]. 
 Multiple epigenetic studies have been conducted using the Rhode Island Child Health 
Study (RICHS), a birth cohort of term pregnancies delivered at Women and Infants’ Hospital in 
Providence, Rhode Island and the findings have been consistent across the different approaches 
and neurobehavioral outcomes [25]. The methylation status of two target genes, Hydroxysteroid 
11- Dehydrogenase 2 (HSD11B2) and Nuclear Receptor Subfamily 3 Group C Member 1 
(NR3C1), have been analyzed in relation to NNNS measures. These genes were selected because 
HSD11B2 is involved in cortisol regulation in the placenta and in the hypothalamic-pituitary-
adrenocortical (HPA) axis. Previous studies have shown that reduced HSD11B2 expression in 
the placenta leads to the fetus being exposed to increased levels of cortisol and dysregulation of 
the infant’s HPA axis and neurodevelopment [79, 80]. NR3C1 is the glucocorticoid receptor 
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gene, which binds cortisol. Placentas of 185 newborn infants were analyzed and showed that the 
promoter region of HSD11B1 was hypermethylated in infants who had reduced scores for quality 
of movement [81]. Similar analyses showed an association between the methylation pattern in 
the promoter region of NR3C1 and the quality of infant movement [82], infant attention [82, 83], 
self-regulation [83], and lethargy [83] . The interaction of DNA methylation of HSD11B2 and 
NR3C1 leads to distinct neurobehavioral phenotypes [84]. For example, when methylation was 
high for both genes the children had higher habituation scores [84].    
 In more recent studies, genome-wide methylation of the placenta was used instead of 
examining specific candidate genes. An epigenome-wide study of 335 infants found that an 
increase in methylation of a CpG site in the Fragile Histidine Triad (FHIT) gene was associated 
with increased infant attention whereas the inverse was true for a CpG site in the Ankyrin Repeat 
Domain 11 (ANKRD11) gene [85]. FHIT is a tumor suppressor gene that has been linked to 
autism spectrum disorder [86] and ANKRD11 acts as a nuclear co-regulator in the developing 
brain [87] and has been associated with KBG syndrome [88], which is associated with 
developmental delays and intellectual deficiencies [89]. In addition to the methylation analysis, a 
gene ontology analysis was conducted on genes represented by CpGs associated with NNNS 
outcomes. The genes with variable methylation were enriched for biological pathways involved 
in both brain development and placental physiology [85].  
Recently, we analyzed genome-wide placental methylation in relation to neurocognitive 
function at 10-years of age. Genes that were associated with neuronal development and function 
displayed hypermethylated in extremely preterm births [90]. This hypermethylation could lead to 
suppressed expression of these genes which are critical for neurodevelopment. There is also an 
association between hypermethylation of 16 genes involved neuronal development and function 
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and moderate to severe cognitive impairment at ten years of age [90]. This is one of the first 
studies that directly analyzes the association of placental methylation and neurocognitive 
outcomes later in life. More studies like this are necessary in order to confirm this association.  
v. Inflammation and Neurodevelopment 
Many studies have shown that inflammation and cytokines can damage the developing 
fetal brain [9, 16-20, 91-93]. Specifically in the placenta, an inflammatory response activates a 
cytokine cascade that can transmit inflammatory signals between maternal and fetal tissues [94]. 
Inflammation of fetal membranes is associated with the upregulation and shedding of cell 
adhesion molecules [95, 96] and elevation of IL-6 levels [97, 98]. These proteins activate fetal 
leukocytes; [99, 100] this activation is associated with white matter damage [101]. Cytokines and 
other large molecules have access to the brain through circumventricular organs, areas in the 
brain that are devoid of the blood-brain barrier [9]. It has been shown that cells in the 
circumventricular organs contain TLR4 and IL-1 receptors [102, 103]. These receptors trigger 
the NF-B signaling cascade that releases multiple cytokine and chemokines that can send 
inflammatory signals to other cells in the central nervous system and cause neuroinflammation 
[104, 105].   
The effects of both prenatal and postnatal inflammation on neurodevelopment have been 
studied. Children exposed to inflammation in utero are at greater risk for developing 
neurological, emotional, and learning disorders, including autism [26, 27, 106-108] (Figure 1). 
The Providence cohort in the Collaborative Perinatal Project was studied to examine the 
association between maternal cytokine levels and adult psychosis. Increased levels of TNF- in 
the maternal serum led to increased odds of schizophrenia and other psychoses in the offspring 
[109]. TNF- has been shown to irreversibly alter synaptic transmission and impair cognition in 
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adult inflammation models [110-112]. Interestingly, in a mouse model study, maternal 
inflammation lead to an increase in placental serotonin output [113]. Maternal serotonin from the 
placenta reaches the fetal brain and modulates key neurodevelopmental processes [114-116].   
The ELGAN study has resulted in multiple analyses of the relationship between  the 
concentrations of 25 inflammation-related proteins in the blood of newborns and 
neurodevelopmental outcomes at  2 years of age, including the Bayley Scales of Infant and 
Toddler Development-II and the Child Behavior Check List (CBCL) [28-31] (Figure 1). Out of 
the 25 inflammation-related proteins 17 of them were associated with developmental impairment 
[28]. The risk of abnormal brain structure and function was found to be increased when at least 
four or more of the inflammation-related proteins were present in the blood [29]. The risk of low 
Mental Development Index (MDI), microcephaly, and attention problems defined by CBCL was 
increased in children whose blood persistently had elevated proteins [29]. The ELGAN 
researchers also followed up with the participants at 10 years of age and conducted another 
neurocognitive assessment (Figure 1). They showed that early elevation of C-reactive protein 
(CRP), TNF-, IL-8, intercellular adhesion molecule (ICAM-1) and erythropoietin were 
associated with low IQ values and moderate to severe cognitive impairment [32]. As was true at 
2 years, the presence of four or more inflammatory proteins in the newborn blood was associated 
with an increased risk of neurocognitive deficiencies,  [29], including intellectual deficit and 
impaired cognitive ability. [32].  
These studies demonstrate the impacts that inflammation can have on neurological 
outcomes later in life. The placenta plays a functional role in fetal neurodevelopment and can 
pass inflammatory signals from mother to fetus; hence inflammation in the placenta can be 
deleterious. Postnatal inflammation can also contribute to neurocognitive delays later in life, as 
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show in in the ELGAN cohort. However, this postnatal inflammation could be sustained from a 
prenatal inflammatory response. Even though there is a lot of research on this subject both 
inflammation and neurodevelopment are extremely complex systems that are not fully 
understood.  
vi. Placental Microorganisms and Neurodevelopment 
Infection of the placenta has associated with adverse neurological outcomes, especially in 
those born preterm [117-119]. The majority of the studies have used indicators of infection such 
as chorioamnionitis, fetal vasculitis, histological evidence, and maternal fever as indicators of 
placental infection. Many of these studies have shown an association between chorioamnionitis 
and cerebral palsy (CP) in both preterm [120] and normal birth weight infants [121]. Cerebral 
white matter damage, identified by ultrasound, is predictive of motor, cognitive, and perceptual 
disorders  [122-127]. Leviton et. al found that indicators of maternal infection and of a fetal 
inflammatory response are associated with cerebral echolucency, an indicator of white matter 
damage [128].  
Few studies have directly tested the placenta for the presence of microorganisms. One 
study detected infectious agents through in situ hybridization or reverse transcriptase-polymerase 
chain reaction (RT-PCR) and demonstrated an association between in utero infection of the 
placenta and neurodevelopmental abnormalities [129]. In the ELGAN study the presence of U. 
urealyticum was associated with increased risk of intraventricular hemorrhage and echolucent 
brain lesions in the white matter [130]. In another study of that cohort, placentas were analyzed 
for multiple microorganisms and infants were assessed for CP at 24 months. Microorganisms 
isolated from the placenta were predictive of ultrasound lesions of the brain and diparetic CP 
[131]. To further our understanding of the relationship between placental microorganisms and 
neurodevelopment, more studies are needed that are based on assays for the presence of 
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microorganisms as opposed to using indicators of infection. Also, assessments of the children 
later in life are needed to determine if the neurodevelopmental delays that have been associated 
with placenta microorganisms persist into later childhood and beyond. 
vii. Project Approach 
 This research focuses microorganisms in the placenta and how they may influence 
neurocognitive function later in life through alterations to the placenta. The central hypothesis 
of this research is that microorganisms in the placenta induce an inflammatory response 
via epigenetic modifications, and that this inflammatory response is associated with a 
decline in neurocognitive function later in life.  This project focuses on different microbial 
species in the placenta and their association with 10 year neurocognitive outcomes, placental 
CpG methylation, and mRNA expression of inflammation-related genes in the placenta. It is 
notable that our research is the first to examine a variety of microbial species in the placenta, as 
opposed to indicators of infection and analyze them in relation to (1) a broad range of 
neurocognitive assessments at 10-years of age, (2) genome-wide CpG methylation patterns in the 
placenta, and (3) placental mRNA expression of inflammation-related genes.  
viii. Dissertation Organization 
 This dissertation is organized into three chapters. The first chapter describes the 
association between microbial species in the placenta and 10year neurocognitive outcomes. The 
second chapter begins to examine placental alterations that could explain the association 
identified in the first chapter by exploring placental CpG methylation patterns in the presence of 
microorganisms. The third chapter focuses in on the inflammation pathway and the relationship   
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between placental microbes and mRNA expression of inflammation-related genes. Of particular 
interest these studies identify mechanisms within the placenta by which microorganisms could 
affect later-life health outcomes.    
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CHAPTER 1: NEUROCOGNITIVE AND SOCIAL-COMMUNICATIVE FUNCTION OF 
CHILDREN BORN VERY PRETERM AT 10 YEARS OF AGE: ASSOCIATIONS WITH 
MICROORGANISMS RECOVERED FROM THE PLACENTA PARENCHYMA 
1.1 Overview 
Children born preterm, before 37 weeks, are at a higher risk for neurocognitive 
impairment [132]. This impairment persists into school age and manifests as poor performance in 
school [133, 134]. Studies have shown a higher incidence of intellectual deficit among children 
born preterm in both childhood [135, 136] and adolescence [137, 138].  While most studies focus 
on intelligence quotient (IQ), children born preterm exhibit impairment in multiple domains of 
neurodevelopment including motor function [134], executive function [138, 139], social 
cognition [140, 141], language skills [142], and mathematic ability [143]. These cognitive 
deficits tend to co-occur in preterm children [134, 144, 145]. As prenatal care continues to 
improve the survival rates of preterm children, the number of these children living with 
neurological deficits and disabilities is increasing [146, 147]. Thus, it is important to understand 
the etiology of neurocognitive impairment and the precursors of unfavorable cognitive outcomes 
in extremely preterm children.  
The developmental origins of health and disease (DOHaD) hypothesis proposes that the 
prenatal environment can influence adult disease and later life outcomes [1, 6], including 
neurocognitive and mental health [3-5]. With relevance to DOHaD, the placenta is a critical 
regulator of the prenatal environment and is at the interface between the mother and developing 
fetus. The placenta transports nutrients from mother to fetus and produces hormones necessary to 
maintain pregnancy and support the fetus [148]. Once considered a sterile organ, the placenta 
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recently has been found to harbor microorganisms [10, 46]. The presence of bacterial species in 
the placenta can affect pregnancy outcomes and fetal health [7, 46]. Preterm birth has been 
associated with microorganisms in the placenta and intrauterine environment [7, 119, 149, 150], 
including Ureplasma urealyticum, Mycoplasma hominis, Gardnerella vaginalis, and 
Peptostreptococcus sp. The presence of bacteria in the placenta is also associated with adverse 
neurological outcomes, especially in those born preterm [117-120]. Most of the studies that 
assessed placental bacteria and neurocognitive outcomes used indicators of infection, such as 
chorioamnionitis, as opposed to directly testing the placenta for the presence of microorganisms, 
a gap that will be addressed in this study.  
1.2 Study Objectives 
For this study, we set out to examine neurocognitive and social-communicative function 
among school-age children in relation to placental bacteria. Previously within the ELGAN study 
it has been observed that children whose placenta harbored two or more organisms, compared to 
those with no or one organism, were at heightened risk of brain abnormalities detected by 
ultrasound and with forms of cerebral palsy two years later [131]. Specifically, the presence of 
Ureaplasma urealyticum was associated with increased risk of intraventricular hemorrhage and 
brain lesions in the white matter [130]. In the present study, we assess the neurological 
development of the ELGAN children at 10 years of age in relation to placental microbes.  The 
goal of these analyses is to provide insights into whether microorganisms in the placenta can 
alter long-term neurocognitive development and social-communicative behavior.  
1.3 Materials and Methods 
1.3.1 ELGAN Study Recruitment and Participation 
The recruitment process of the ELGAN study has previously been described [151]. 
Briefly, between 2002 and 2004, women who gave birth before 28 weeks gestational age at one 
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of the 14 ELGAN research sites in the United States were asked to participate in the study. The 
Institutional Review Boards at each of the 14 study sites approved all procedures. Informed, 
written consent was provided within a few days before or after delivery. The mother’s consent 
covered both her and the child’s participation in the study.  
A total of 1,249 mothers and 1,506 infants enrolled in the study of which 1,365 placentas 
were collected and analyzed for microorganisms. When children reached 2 years of adjusted age, 
1102 participated in a neurodevelopmental assessment [151]. At the 10 year follow-up, 889 
children were enrolled and evaluated. Of these children, 807 had their placenta parenchyma 
cultured and analyzed for microorganisms. These 807 participants made up the subcohort we 
included in this study.   
1.3.2 Demographic and Pregnancy Variables  
Following delivery, a trained research nurse interviewed each mother in her native 
language using a structured data collection form and following procedures defined in a manual. 
The mother’s report of her own characteristics and exposures, as well as the sequence of events 
leading to preterm delivery were taken as truth, even when her medical record provided 
discrepant information. 
Shortly after the mother’s discharge, the research nurse reviewed the maternal chart using 
a second structured data collection form. The medical record was relied on for events following 
admission. The clinical circumstances that led to preterm delivery were operationally defined 
using both data from the maternal interview and data abstracted from the medical record [152]. 
Each mother/infant pair was assigned to the category that described the primary reason for 
preterm delivery. 
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1.3.3 Newborn Variables 
The gestational age estimates were based on a hierarchy of the quality of available 
information. Most desirable were estimates based on the dates of embryo retrieval or intrauterine 
insemination or fetal ultrasound before the 14th week (62%). When these were not available, 
reliance was placed sequentially on a fetal ultrasound at 14 or more weeks (29%), last menstrual 
period (LMP) without fetal ultrasound (7%), and gestational age recorded in the log of the 
neonatal intensive care unit (1%). 
The birth weight Z-score is the number of standard deviations the infant’s birth weight is 
above or below the median weight of infants at the same gestational age in referent samples not 
delivered for preeclampsia or fetal indications [128, 153].   
1.3.4 Placenta Sample Collection  
Women participating in the ELGANs study were asked to provide their placentas for 
analysis. The placenta collection technique is as follows: delivered placentas were placed in a 
sterile exam basin and transported to a sampling room where they were biopsied at the midpoint 
of the longest distance between the cord insertion and the edge of the placental disk. Using 
sterile technique, the amnion was pulled back to expose the chorion. Traction was applied to the 
chorion and a piece of the underlying trophoblast tissue was removed. The tissue was placed into 
a cryo-vial and immediately immersed into liquid nitrogen. Specimens were stored until 
processing at minus 80°C [154]. 
1.3.5 Bacterial Analysis of Placenta 
Study placentas were biopsied following delivery and were assessed for microorganisms 
as described previously [154]. Briefly, a sterile scalpel was used to remove a section of each 
placenta. The placental tissue was homogenized in a phosphate buffered saline solution (PBS) 
and serial dilutions of the homogenate were made in PBS. Aliquots of the original homogenate 
21 
as well as the dilutions were plated onto selective and nonselective media, including: pre-reduced 
Brucella base agar, tryptic soy agar, chocolate agar, and A-7 agar. Following the incubation 
period various colony types were enumerated, isolated, and identified at the Brigham and 
Women’s Microbiology Laboratory using estimated criteria [155]. Since the constituents of the 
chorion parenchyma in the ELGANs study prevent the reliable detection of bacterial DNA by 
polymerase chain reaction techniques, this study assessed placental colonization patterns 
obtained only by culture techniques.   
1.3.6 Procedures for the Assessments at 10-years of Age 
All families who participated in the 2 year follow up were contacted by mail and then by 
phone to invite them to participate in the 10 year follow up. Lost to follow up families were 
searched for on state vaccination registries, and other openly-available websites. Facebook was 
also used where approved by the local institution’s IRB.  
Families willing to participate were scheduled for one visit during which all of the 
measures reported here were administered in three to four hours, including breaks. The 
assessments were selected to provide the most comprehensive information about neurocognitive 
and academic function in one testing session (Table 1). While the child was tested, the parent or 




Table 1. Description of neurocognitive assessment variables at 10 years of age 
Measure Type Assessment Variable Description 
Neurocognitive 
Measures 
Latent Profile Analysis (LPA) Includes 9 variables that assess IQ and 
executive function and categorize children 
into four neurocognitive groups: normal, 
low-normal, moderately impaired, and 
severely impaired 
Oral and Written Language 
Scales (OWLS) Oral Composite 
Expressive and receptive language skills 
Wechsler Individual 
Achievement Test-III (WIAT-
III) Numerical Operations 
Academic function in mathematics 




Social Responsiveness Scale 
(SRS) 
Identifies social impairment associated 
with autism spectrum disorder (ASD) 
Children’s Communication 
Checklist-2 (CCC-2) Pragmatic 
Language 
Speech, vocabulary, sentence structure, 
and social language skills 
 
1.3.6.1 Neurocognitive Outcomes 
1.3.6.1.1 Cognitive Function Derived from Latent Profile Analysis (LPA) 
This outcome variable was derived from latent profile analysis of participants’ 
performances across nine measures of IQ and executive function, described in detail elsewhere 
[156]. IQ was assessed with the School-Age Differential Ability Scales-II (DAS-II) Verbal and 
Nonverbal Reasoning scales [157]. Executive function included two subtests from DAS-II, DAS 
Recall of Digits Backward and Recall of Sequential Order, which measured verbal working 
memory [157], and five subtests from the NEPSY-II (A Developmental NEuroPSYchological 
Assessment-II) [158]. The NEPSY-II Auditory Attention and Response Set measured auditory 
attention, set switching and inhibition, the NEPSY-II Inhibition and Inhibition Switching 
measured simple inhibition and inhibition in the context of set shifting, respectively, and the 
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NEPSY-II Animal Sorting measured visual concept formation and set shifting. The LPA 
identified four subgroups of study participants with similar cognitive profiles: normal, low-
normal, moderately impaired, and severely impaired.   
1.3.6.1.2 Oral and Written Language Scales (OWLS) Oral Composite 
Expressive and receptive language skills were evaluated with the Oral and Written 
Language Scales (OWLS), which assess semantic, morphological, syntactic, and pragmatic 
production and comprehension of elaborated sentences [159]. The OWLS yields an oral 
composite score that includes both listening comprehension and oral expression. To correct for 
small differences in age at the time of assessment and to facilitate a comparison of our findings 
to those reported for term children we calculated Z-scores based on distributions of values 
reported for the historical normative samples that are described [159]. 
1.3.6.1.3 Academic Function  
Academic function was measured with the Wechsler Individual Achievement Test-III 
(WIAT-III) Word Recognition and Numerical Operations subtests [160]. For these tests, we 
again used Z-scores based on distributions of values reported for the historical normative 
samples [160]. 
1.3.6.2  Social-Communicative Outcomes  
1.3.6.2.1 Social Responsiveness Scale (SRS) 
The SRS identifies social impairment associated with autism spectrum disorder (ASD) 
and quantifies its severity [161]. This 65-item instrument provides a total score reflecting 
severity of social deficits in the autism spectrum. Raw scores are converted to T-scores to 
account for gender and age differences [161]. 
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1.3.6.2.1 Children’s Communication Checklist-2 (CCC-2) Pragmatic Language 
The Children’s Communication Checklist-2 (CCC-2) was used to assess children’s 
pragmatic language skills [162]. The child’s pragmatic language ability is assessed with four 
CCC-2 subscales: Initiation, Scripted Language, Context, and Nonverbal Communication. For 
each child, we averaged the scaled scores for these four subtests to yield a CC-2 pragmatic 
language composite score. 
1.3.7 Data Analyses 
In order to determine whether placental microorganisms are associated with 
neurocognitive and social-communicative function at age 10, separate logistic regression models 
were performed for 15 bacteria species or groups assessed including: Lactobacillus sp., 
Prevotella bivia, Gardnerella vaginalis, anaerobic Streptococcus, Peptostreptococcus sp., 
Escherichia coli, alpha-hemolytic Streptococcus, Ureaplasma urealyticum, Mycoplasma sp., 
Staphyloccocus sp., Propionibacterium sp., Actinomyces sp., Corynebacterium sp., 
Streptococcus Group B, and Streptococcus Group D. Each model examined whether the presence 
of an individual bacterial species or bacterial type was associated with increased odds of scoring 
one or more standard deviations below the normative mean on five different assessments: OWLS 
Oral Language Composite, WIAT-III Word Recognition, WIAT-III Numerical Operations, SRS, 
and CCC-2 pragmatic language. In the case of LPA, the models examined whether the presence 
of an individual bacterial species or type was associated with increased odds of having moderate 
or severe cognitive impairment. Confounders included in the models were infant sex, gestational 
age, birth weight Z-score < -1, maternal education, antenatal steroids, and mother’s eligibility for 
government-provided medical-care insurance. These models yielded odds ratios (ORs) and 95% 
confidence intervals (CI) of each 10-year characteristic associated with the microbial organisms 
recovered from the placenta. Bacterial species were considered to be significantly associated 
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with a neurological function if p-value <0.05 and the OR 95% CI did not include one. An 
organism was considered to be associated with an increased risk of preforming poorly on an 
assessment when the OR and 95% CI were above one. Conversely, a microorganism was 
considered to have a protective effect when the OR and 95% CI were below one. 
1.4 Results 
1.4.1 Study Subject Characteristics  
The placentas of 807 of the 889 ELGAN subjects who participated in the 10-year follow-
up assessment were analyzed for microbial presence. These 807 individuals represented those for 
whom microbial placental data were available and make up our subcohort for this study. The 
subcohort is similar to the overall 10-year cohort as is demonstrated by similarities in the 
percentages across variables (Table 2). Within the subcohort there are slightly more males than 
females (51% versus 49%). Most of the children were born between 25 and 26 weeks (44%) 
while 278 (34%) were born during the 27th week and 173 (21%) were born between 24 and 25 
weeks. Sixty-five percent of mothers had private insurance; 35% had public insurance. Fourteen 
percent of mothers had completed 12 or fewer years of formal education, 48% completed more 
than 12 years but less than 16 years, and 35% completed 16 or more years. Ninety percent of 
mothers were treated with antenatal corticosteroids. Outcome data were missing from between 
5% for OWLS Oral Language Composite scores and 2% for the WIAT-III Numerical Operation 
score and the LPA.  
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Table 2. Demographics 
 Overall 10-year 
follow up (n=889) 
N (%) 
Subcohort of 10-year participants 
with placenta microbiology (n=807) 
N(%) 
Fetal Sex   
Male 455 (51.2) 414 (51.3) 
Female 434 (48.8) 393 (48.7) 
Gestational Age (weeks)   
24-25 187 (21.0) 173 (21.4) 
25-26 400 (45.0) 356 (44.1) 
27 302 (34.0) 278 (34.4) 
Birth weight (Z-score)   
< -2 53 (6.0) 48 (5.9) 
 -2, < -1 120 (13.5) 107 (13.3) 
 -1 716 (80.5) 652 (80.8) 
SES (insurance)   
Public 307 (34.5) 271 (33.6) 
Private 568 (63.9) 524 (64.9) 
NS 14 (1.6) 12 (1.5) 
Maternal Education, years   
 12 (high school) 126 (14.2) 112 (13.9) 
Some College or 
Associates Degree 
431 (48.5) 387 (48.0) 
College or Higher 306 (34.4) 284 (35.2) 
NS 26 (2.9) 24 (3.0) 
Antenatal corticosteroids   
Yes 788 (88.6) 723 (89.6) 
No 100 (11.2) 84 (10.4) 
NS 1 (0.1) 0 (0) 
LPA    
Yes 874 (98.3) 792 (98.1) 
No 15 (1.7) 15 (1.9) 
OWLS oral composite   
Yes 849 (95.5) 771 (95.5) 
No 40 (4.5) 36 (4.5) 
WIAT-III word recognition   
Yes 864 (97.2) 783 (97.0) 
No 25 (2.8) 24 (3.0) 
WIAT-III numerical operations   
Yes 874 (98.3) 792 (98.1) 
No 15 (1.7) 15 (1.9) 
SRS   
Yes 866 (97.4) 787 (97.5) 
No 23 (2.6) 20 (2.5) 
CCC-2 Pragmatic Language   
Yes 854 (96.1) 775 (96.0) 
No 35 (3.9) 32 (4.0) 
NS = Not Specified  
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 The most common bacteria present in the study placentas was Staphylococcus sp. which 
was detected in 94 (11.6%) placentas (Table 3). The least prevalent bacterial species detected 
was G. vaginalis, which was present in 28 (3.5%) placentas. The remaining bacterial species 
were found in between 36 (4.5%), in the case of Streptococcus Group D, and 64 (7.9%), in the 
case of Corynebacterium sp., placentas. This includes U. urealyticum, Lactobacillus sp., E. coli, 
and alpha-hemolytic Streptococcus which were detected in 43 (5.3%), 48 (5.9%), 49 (6.1%), and 
53 (6.6%), respectively. 
Table 3. Presence of microorganisms in the placenta 
Bacteria n (%) 
Lactobacillus sp. 48 (5.9) 
P. bivia 41 (5.1) 




Peptostreptococcus sp. 49 (6.1) 
E. coli 49 (6.1) 
Alpha Streptococcus 53 (6.6) 
U. urealyticum 43 (5.3) 
Mycoplasma sp. 42 (5.2) 
Propionibacterium sp. 55 (6.8) 
Actinomyces sp. 47 (5.8) 
Corynebacterium sp. 64 (7.9) 
Staphylococcus sp.  94 (11.6) 
Streptococcus Group B 38 (4.7) 
Streptococcus Group D 36 (4.5) 
 
1.4.2 Association of Neurocognitive and Social-Communicative Function at Age 10 in 
ELGAN Placentas Exposed to Bacteria  
Out of the four neurocognitive assessments analyzed, three (WIAT-III Numerical 
Operations, OWLS Oral Language Composite, and LPA of IQ and EF) were associated with 
statistically significant differential odds in relation to at least one type of microorganism. Neither 
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of the social-communicative assessments displayed differential odds in relation to any of the 15 
microbial species.   
1.4.2.1 WIAT-III Numerical Operation 
For five of the 15 microorganisms detected, bacterial presence in the placenta was 
associated with increased odds of scoring one or more standard deviations below the normative 
mean on the WIAT-III Numerical Operations assessment (Figure 3). The strongest association 
was found with U. urealyticum (OR, 95% CI: 2.21, 1.16 – 4.26). Other bacteria associated with a 
low score on the WIAT-III Numerical Operations test were E. coli (OR, 95% CI: 1.94, 1.04 – 
3.65), alpha-hemolytic Streptococcus (OR, 95% CI: 1.88, 1.03 – 3.45), Corynebacterium sp. 
(OR, 95% CI: 1.88, 1.08 – 2.68), and Staphylococcus sp. (OR, 95% CI: 1.67, 1.04 – 2.68). 
 
Figure 3. Odds ratios and 95% confidence intervals for WIAT-III Numerical Operations in 
relation to placental microorganisms. The forest plot displays ORs and 95% confidence 
intervals of a Z-score  -1 on the WIAT-III Numerical Operations subtest at age 10 associated 
with the isolation of 16 bacterial species (y-axis). These odds ratios are adjusted for fetal sex, 
gestational age, birth weight Z-score, maternal education, public insurance, and antenatal 
corticosteroid use.  
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1.4.2.2 OWLS Oral Language Composite  
For three of the 15 microorganisms in the placenta, bacterial presence was associated 
with increased odds of scoring one or more standard deviations below the normative mean on the 
OWLS Oral Language Composite assessment (Figure 4). The strongest association was for G. 
vaginalis (OR, 95% CI:  3.20, 1.22 – 9.99). The other two bacteria associated with a low score 
on the OWLS were U. urealyticum (OR, 95% CI: 2.38, 1.22 – 4.85) and Staphylococcus sp. (OR, 
95% CI: 1.73, 1.07 – 2.82). The presence of Lactobacillus sp. was associated with decreased 
odds of a low score on the OWLS (OR, 95% CI: 0.5, 0.25 – 0.96). 
 
Figure 4. Odds ratios and 95% confidence intervals for OWLS Oral Composite in relation 
to placental microorganisms. The forest plot displays ORs and 95% confidence intervals of a 
Z-score  -1 on the OWLS Oral Composite score at age 10 associated with the isolation of 16 
bacterial species (y-axis). These odds ratios are adjusted for fetal sex, gestational age, birth 




The presence of Lactobacillus sp. in the placenta was associated with decreased odds 
(OR, 95% CI: 0.27, 0.09 - 0.67) of having moderate or severe impairment as determined by LPA 
(Figure 5). The other 14 microorganisms were not associated with LPA outcomes.  
 
Figure 5. Odds ratios and 95% confidence intervals for LPA in relation to placental 
microorganisms. The forest plot displays ORs and 95% confidence intervals of a LPA 
subgrouping of severely or moderately impaired at age 10 associated with the isolation of 16 
bacterial species (y-axis). These odds ratios are adjusted for fetal sex, gestational age, birth 
weight Z-score, maternal education, public insurance, and antenatal corticosteroid use.  
 
1.4.3 Lactobacillus Interaction Analysis 
In our analysis, Lactobacillus sp. was associated with lower odds of scoring low on the 
OWLS Oral Language Composite and lower odds of having moderate to severe cognitive 
impairment as characterized by LPA. Thus, we added an interaction term in the model between 
Lactobacillus sp. and the other 14 microorganisms to evaluate whether the effect of the 
interaction would significantly affect the ORs of our outcomes. However, we did not observe any 
significant effects in this analysis.  
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1.5 Discussion 
In this study, several species of bacteria found in the placenta of children born extremely 
preterm were associated with neurocognitive impairments at 10 years of age. We demonstrate 
that bacteria associated with one or more adverse neurocognitive outcomes included U. 
urealyticum, alpha-hemolytic Streptococcus, Corynebacterium sp., G. vaginalis and 
Staphylococcus sp. In contrast, the presence of Lactobacillus sp. was associated with a lower risk 
of two adverse neurodevelopmental outcomes, general cognitive impairment and language 
deficit. Interestingly, bacterial presence in the placenta had no significant effects on social-
communicative function.   
Intrauterine and neonatal infection are strongly associated with negative birth outcomes, 
such as preterm birth [7], and also neurodevelopmental impairment [163, 164]. In the present 
study, infection of the intrauterine environment with U. urealyticum was found to be associated 
with deficits in language and mathematics. This same bacteria was previously associated with an 
inflammatory response in the chorioamnion, or chorioamnionitis [36, 165], as well as in the 
amniotic fluid, cord blood, and fetal tissues [166, 167]. Providing further support for the present 
findings, the presence of U. urealyticum in the amniotic fluid has been found to be predictive of 
neuromotor delays at age 2 in a preterm birth cohort study [168]. Within the ELGAN cohort, U. 
urealyticum in the placenta has been associated with fetal and maternal inflammation as well as 
white matter damage [130]. In addition to the findings with U. urealyticum, in the current study 
E. coli was associated with increased risk of performing poorly on WIAT-III Numerical 
Operations. This is interesting as in prior studies, exposure to E. coli increased the likelihood of 
white matter damage [169, 170]. White matter damage in newborns is predictive of a range of 
adverse neurodevelopmental outcomes including cerebral palsy, autism spectrum disorder, and 
psychiatric disorders [125, 171-173], but has yet to be evaluated as an antecedent of learning 
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limitations in children born very preterm.  In terms of a mechanism linking bacterial presence to 
neurodevelopmental outcomes, microorganisms induce cytokine production in trophoblasts in 
both cell culture and in mouse models [21, 22]. Inflammation can damage the developing fetal 
brain [9, 16, 18, 20] and has been associated with neurological delays later in life [29, 31, 32].  
In contrast to the other microorganisms, Lactobacillus sp. was associated with a 
decreased risk of oral language and general cognitive impairment, as measured by LPA. In 
certain contexts, Lactobacillus sp. has an anti-inflammatory effect; either by inhibiting NF-B 
[174], a pro-inflammatory pathway, or by inducing the production of interlukin-10, an anti-
inflammatory cytokine, in trophoblast cells [175]. In the ELGAN cohort, the presence of 
Lactobacillus sp. in the placenta was associated with a lower likelihood of neonatal systemic 
inflammation [23]. Analyses to determine to what extent the presence of Lactobacillus sp. 
counteracts the effect of the other microorganisms in the placenta did not detect an interaction, 
perhaps because only a small number of placentas had Lactobacillus sp. present along with each 
of the other microbial types. For example, in only 1.4% of placentas was Lactobacillus sp. 
accompanied by Staphylococcus sp, the species found most often in our sample of placenta. No 
placentas harbored Lactobacillus sp. and either U. urealyticum or Streptococcus Group B.  
 Few studies have focused on the question of whether specific microorganisms in the 
placenta are associated with neurocognitive and social-communicative outcomes later in life. The 
majority of studies on this topic have used indicators of infection, such as chorioamnionitis and 
fetal vasculitis, which are typically associated with genital mycoplasmas [166, 176, 177], to 
quantify placental infection [120, 121] instead of testing the placenta for specific 
microorganisms, as we did in this study. Previous ELGAN work considers specific bacterial 
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species in the placenta in relation to short-term neurological outcomes at age 2 [129, 131]. 
However, the long-term outcomes have not been previously studied.   
While we have identified associations between microbes in the placenta and 
neurocognitive outcomes our study is not without limitations. There was a relatively low 
prevalence of each individual bacterium, limiting the power to detect associations. Nevertheless, 
387 (48%) of the placentas in this study harbored at least one type of microorganism, which is 
consistent with findings reported by others [46]. Another limitation was that detection of 
placental microbes was based on culture techniques. Therefore, only specific bacteria were 
identified. Other bacterial species were likely present in the placenta samples. Future research 
could include a microbiome assessment to further evaluate non-culturable bacteria present in 
placentas and their associations with birth outcomes. Strengths of this study are the large sample 
size, the broad range of assessments of neurocognitive and academic achievement, and the 
blinding of individuals who performed the neurodevelopmental assessments to information about 
placental microorganisms. 
In summary, there were three major findings from this study. First, the presence of 
several different types of microorganisms in the placenta was associated with increased risk of 
learning limitations at age 10 among individuals born extremely preterm. Second, with 
importance to identification of potential intervention-based research, Lactobacillus sp. was 
associated with a lower risk of these learning limitations.  Finally, while placental 
microorganisms were associated with altered risk of neurocognitive outcomes they did not show 
an association with social-communicative function including autism. These results are relevant to 
the study of prenatal factors that influence neurocognitive function of children later in life.  
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CHAPTER 2: MICROORGANISMS IN THE HUMAN PLACENTA ARE ASSOCIATED 
WITH ALTERED CPG METHYLATION OF IMMUNE AND INFLAMMATION-
RELATED GENES 
2.1 Overview 
The placenta is a critical regulator of the prenatal environment and is essential for a 
healthy pregnancy and fetal development. It transports nutrients from mother to fetus and 
produces hormones necessary to maintain pregnancy and support the fetus [148]. The placenta 
can also harbor bacterial communities that, depending on their composition, affect pregnancy 
outcomes and fetal health [7, 46]. Previously it was thought that all bacteria in the placenta 
originate from infections of the lower genital tract [7], however, a number of studies have found 
that bacteria in the placenta are derived from vaginotropic non-infectious microflora [154, 178]. 
In addition, bacteria derived from other tissues may contribute to the placental microbiome, such 
as the oral cavity [10]. For example, it has been proposed that oral bacteria can translocate to the 
placenta by hematogenous transmission [44].   
Importantly, certain bacteria in the placenta have been associated with deleterious 
pregnancy outcomes including preterm birth [7]. Among these placental bacteria are Ureplasma 
urealyticum, Mycoplasma hominis, Gardnerella vaginalis, and Peptostreptococcus sp., which are 
all associated with bacterial vaginosis, a disruption in the vaginal microbiota. Other placental 
bacteria, Group B Streptococcus and Escherichia coli, are associated with chorioamnionitis and 
fetal infection [7]. Little is known about the molecular responses to microorganisms in the 
placenta that potentially alter pregnancy and fetal outcomes.  
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The placental epigenome, particularly DNA methylation, is a potential mechanism that 
could explain this association and has not been explored. Epigenetic changes, such as DNA 
methylation, have been associated with bacteria in other tissues including Helicobacter pylori in 
the gastric mucosa [70, 179, 180], uropathogenic Escherichia coli in uroepithelial cells [69] and 
Campylobacter rectus in murine placental tissue [24]. In human placental cell culture, the 
presence of bacteria has been associated with both pro- and anti- inflammatory responses 
mediated by cytokines [21]. With an intriguing potential for sustained inflammation, our team 
showed in the Extremely Low Gestation Age Newborns (ELGAN) cohort that vaginotropic 
placental bacteria were associated with distinct inflammatory protein profiles in newborn blood 
with Lactobacillus sp. being anti-inflammatory and bacterial vaginosis-associated bacteria being 
pro-inflammatory [23]. These varying inflammatory responses induced by placental bacteria 
might be driven by CpG methylation in the placenta which could impact both placental function 
and fetal well-being.  
2.2 Study Objectives 
To our knowledge, this is among the first studies to assess placental CpG methylation in 
relation to placenta bacteria. Here we investigated whether placental microbes were associated 
with altered placental DNA cytosine proximal to guanine (CpG) methylation patterns in the 
ELGAN cohort.  The goal of these analyses was to provide insights into how microorganimsms 
in the placenta alter the placental methylome and could thereby influence pregnancy and 
neonatal health outcomes.   
2.3 Materials and Methods  
2.3.1 ELGANs Study Subject Recruitment 
The recruitment process for the ELGAN study has been described in detail [151]. Briefly, 
between 2002 and 2004, we invited women who gave birth before 28 weeks gestational age at 
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one of the 14 hospitals in 5 states in the United States to participate in the study. A total of 1,249 
mothers and 1,506 infants enrolled in the study of which 1,365 placentas were collected and 
analyzed for microorganisms. A subcohort of 84 mother/infant pairs with similar average 
gestational and maternal age as the overall cohort were investigated in the present study (Table 
4).   
Table 4. Demographics 
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The Institutional Review Boards at all 14 ELGAN study sites approved all procedures. 
Informed, written consent was provided within a few days of delivery, either before or after. The 
mother’s consent covered both her and the child’s participation in the study.   
2.3.2 Bacterial Analysis of Placenta 
The placentas were biopsied as soon as possible after delivery and were assessed for 
microorganisms as described [154]. Briefly, a section of each placental specimen was removed 
using a sterile scalpel and homogenized in a phosphate buffered saline solution (PBS). Serial 
dilutions of the homogenate were made in PBS and aliquots of the original homogenate and the 
dilutions were plated onto selective and nonselective bacteriologic media, which included: 
prereduced Brucella base agar, tryptic soy agar, chocolate agar, and A-7 agar. Following 
incubation the various colony types were enumerated, isolated, and identified at the Brigham and 
Women’s Microbiology Laboratory using established criteria [155]. Since we have determined 
the constituents of the chorion parenchyma in the ELGANs prevent the reliable detection of 
bacterial DNA by PCR techniques, this study assessed only placental colonization patterns 
obtained by culture techniques.   
2.3.3 DNA Extraction and Assessment of DNA Methylation 
DNA extraction and assessment of DNA methylation by taking a 0.2 g subsection of 
placental tissue was cut from the frozen biopsy of dry ice, washed with sterile 1X PBS to remove 
residual blood, and homogenized with B-mercaptoethanol in Buffer RLT (Qiagen, Valencia, 
CA). DNA and RNA sequences with 18 or more nucleotides in length were collected using the 
AllPrep DNA/RNA/miRNA Universal Kit (Qiagen, Valencia, CA) following the manufacturer’s 
instructions. CpG methylation was assessed using the Illumina Human Methylation450 
BeadChip array (Illumina, Inc., San Diego, CA). This technology asses the DNA methylation 
levels of 486,428 individual probes at single nucleotide resolution. Isolated DNA was bisulfate-
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converted using the EZ DNA methylation kit (Zymo Research, Irvine, CA) and converted DNA 
was hybridized onto the array. The DNA methylation data was collected at Expression Analysis, 
Inc. (Durham, NC; www.expressionanalysis.com).  
 Methylation levels were calculated and expressed as  values ( = intensity of the 
methylated allele (M) / (intensity of the unmethylated allele (U) + intensity of the methylated 
allele (M) + 100) [181]. Batch effect was not a significant source of variation, as determined by 
principle component analysis (PCA). Based on manufacturer recommendations, probes that had 
high detection P-values (P>0.1) were removed from analysis (n=24,591). Following data 
filtration, data were normalized using the beta-mixture quantile (BMIQ) normalization method 
using the wateRmelon package (version 1.11.0) in R (version 3.2.3). After normalization, probes 
that were annotated as single nucleotide polymorphisms (SNPs) by Illumina were removed from 
further analysis (n=84,121), leaving a total of 377,716 probes, representing 20,418 genes. The 
rationale for this exclusion is that SNP variation can lead to false readings of DNA methylation 
signals that may be attributed to genomic variation rather alterations in actual methylation levels 
[182]. 
2.3.4 Statistical Analysis 
 In order to determine whether the placental microbiome is associated with differences in 
DNA methylation patterning of the placenta, Analysis of Covariance (ANCOVA) was 
performed. There were 16 bacterial species assessed including: Lactobacillus sp., Prevotella 
bivia, Gardnerella vaginalis, anaerobic Streptococcus, Peptostreptococcus sp., Escherichia coli, 
alpha-hemolytic Streptococcus, Ureaplasma urealyticum, Mycoplasma sp., Staphyloccocus sp., 
Propionibacterium sp., Actinomyces sp., Corynebacterium sp., Staphylococcus aureus, 
Streptococcus Group B, and Streptococcus Group D. Each model examined whether presence or 
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absence of an individual bacterial species or bacterial type was associated with differential 
placental methylation at any of the 377,716 probes. In the present study, variables were classified 
as confounding if they displayed an association with both the exposure, placental 
microorganisms, and the outcome, DNA methylation. Models were adjusted based on several 
dichotomous variables including fetal-sex, maternal race, whether the mother took an antibiotic 
during pregnancy, whether the mother experienced a vaginal infection during pregnancy, 
whether the mother experienced a urinary tract infection (UTI) during pregnancy, and whether 
the birth occurred via C-section. As there is no evidence that maternal age is associated with the 
presence of microorganisms in the placenta, it was not included as a confounding variable. 
Bacterial species were considered to be significantly associated with methylation if p-value 
<0.05 and the false discovery rate-corrected p-value <0.1 for any given probe. Each bacterial 
species was modeled individually and data analysis was carried out using Partek Genomic Suites 
6.6. 
2.3.5 Gene Set-Based Analysis 
 The differentially methylated probes and corresponding genes were analyzed to 
determine if they were enriched for specific biological functions. Four gene sets were analyzed 
where gene content was established using www.uniprot.org. The four gene sets that were tested 
were selected for their known roles in fetal development: transport-related genes (n=3,704) 
[183], immune-related genes (n=1,622) [183-185], inflammation-related genes (n=410) [184, 
186] and growth/transcription factor-related genes (n=2030) [187-189]. A χ2 test was used to 
identify enrichment of key processes. Once the enriched processes were identified a right-tailed 
Fisher Exact test (=0.05) was conducted on the significant genes in the enriched pathways to 
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identify enriched canonical pathways and transcription factors using Ingenuity Pathway Analysis 
software as described in Martin et al., 2015 [190]. 
2.4 Results 
2.4.1 Study Subject Characteristics   
The placentas of 84 subjects within the ELGAN cohort were analyzed for this study. The 
average gestational age and maternal age of the subcohort of 84 are the same as the overall 
cohort (n=1,365) (Table 4).  There are some differences between the subcohort and the overall 
cohort, including maternal race and sex of the infant. The overall cohort is predominately white 
(58%) while the subcohort is 45% white and 55% non-white. The majority of the infants in both 
the overall cohort and subcohort are males. However, the percentage of males in the subcohort 
(69%) is much larger than the percentage in the overall cohort (45%). Of the 84 infants, 23 
(27%) were delivered vaginally, while 61 (73%) were delivered by Cesarean section. Of these, 
37 (44%) were on public insurance and 46 (55%) were on private insurance. A total of 11 (13%) 
of the women had a urinary tract infection, 16 (19%) had a vaginal infection, and 19 (22%) used 
an antibiotic during pregnancy.  
 The most common bacteria present in the study placentas was Propionbacterium sp. 
which was detected in 10 (11.9%) placentas (Table 5). This was followed closely by 
Staphylococcus aureus which was detected in seven (8.3%) placentas. Ureaplasma urealyticum 
was detected in five (6.0%) and Actinomyces was detected in four (4.8%). Lactobacillus sp. was  
detected in three (3.6%) of placentas and Escherichia coli was detected in two (2.4%) placentas. 
The majority of the microorganisms were present in two to three placentas and 44 (52%) of the 






Table 5. Presence of microorganisms in the placenta and methylation of CpG probes and associated genes 
  CpG Probes Genes 









Lactobacillus sp. 3 (3.6) 44 10 (23) 34 (77) 32 6 (19) 26 (81) 
P. bivia 3 (3.6) 63 13 (21) 50 (79) 49 12 (24) 37 (76) 
G. vaginalis 3 (3.6) 53 16 (30) 37 (70) 43 11 (26) 32 (74) 
Anaerobic Streptococcus 4 (4.8) 0 -- -- 0 -- -- 
Peptostreptococcus sp. 3 (3.6) 13 1 (8) 12 (92) 11 1 (9) 10 (91) 
E. coli 2 (2.4) 53 24 (45) 29(55) 24 6 (25) 18 (75) 
Alpha Streptococcus 3 (3.6) 167 35 (21) 132 (79) 105 13 (12) 92 (88) 
U. urealyticum 5 (6.0) 21 11 (52) 10 (48) 11 6 (55) 5 (45) 
Mycoplasma sp.  9 (10.7) 0 -- -- 0 -- -- 
Staphylococcus sp. 7 (8.3) 40 25 (63) 15 (37) 22 8 (36) 14 (64) 
Propionibacterium sp. 10 (11.9) 2 2 (100) 0 (0) 1 1 (100) 0 (0) 
Actinomyces sp. 4 (4.8) 2 0 (0) 2 (100) 1 0 (0) 1 (100) 
Corynebacterium sp. 3 (3.6) 24 2 (8) 22 (92) 18 1 (6) 17 (94) 
Staphylococcus aureus 7 (8.3) 40 25 (63) 15 (37) 22 8 (36) 14 (64) 
Streptococcus Group B 2 (2.4) 1,257 28 (2) 1,229 (98) 802 12 (1) 790 (99) 





2.4.2 Identification of Differentially Methylated Probes in ELGAN Placentas Exposed to 
Bacteria   
Placental CpG methylation differences were analyzed within the ELGAN cohort between 
84 individuals with or without placental microbes for 377,716 CpG probes representing 20,418 
genes. Statistical significance was adjusted using false discovery rate-corrected p-values (q<0.1). 
Of the 16 microbial species all but two, namely anaerobic Streptococcus and Mycoplasma sp., 
were associated with differentially methylated probes. A total of 1,789 probes, corresponding to 
1,079 genes, were significantly differentially methylated between placentas that harbored 
bacteria and placentas that did not. The probes that displayed differential methylation were 
unique depending on which bacteria was present (Figure 6).  
 
Figure 6. Heatmap of differentially methylated CpG probes corresponding to each of the 
microorganisms. The heatmap displays the 1,789 differentially methylated probes in relation to 





 The microbial species that was associated with the greatest number of altered CpG sites 
was Streptococcus Group B with 1,257 differentially methylated CpG probes (n=802 genes) 
(Table 5). The methylation pattern for Streptococcus Group B leans heavily toward 
hypomethylation with 98% (1,232) of the sites being hypomethylated.  
Following Streptococcus Group B, the two microbial species that were associated with 
the most differentially methylated probes were Streptococcus Group D and alpha-hemolytic 
Streptococcus with 206 and 167 CpG probes, respectively. Most of the probes altered in relation 
to Streptococcus Group D were hypermethylated (62%) while alpha-hemolytic Streptococcus-
associated probes were mostly hypomethylated (79%). The CpG probes correspond to 112 genes 
for Streptococcus Group D and 105 genes for alpha-hemolytic Stretptococcus. The presence of 
E.coli was associated with 53 CpG probes representing 43 different genes. Of those probes 55% 
were hypomethylated. 
2.4.3 Location of Differentially Methylated Probes   
The majority of the significant CpG probes for all 14 bacterial species were located in the 
body of the gene (Table 6). Both of the probes associated with Propionibacterium sp. were 
located in the gene body. Peptostreptococcus sp. had the next highest percentage of differentially 
methylated probes in the gene body at 62%, while Actinomyces sp. had the lowest percentage at 
22%. There were also a large percentage of probes that did not correspond with a gene and 
therefore do not have a gene location. The remaining probes fell into the 1st exon, 3’UTR, 

























Lactobacillus sp. 2 (5) 2 (5) 0 (0) 26 (59) 3 (6) 2 (5) 9 (20) 44 
P. bivia 0 (0) 4 (6) 3 (5) 28 (44) 7 (11) 8 (13) 13 (21) 63 
G. vaginalis 0 (0) 5 (9) 5 (9) 31 (59) 2 (4) 3 (6) 7 (13) 53 
Peptostreptococcus sp.  0 (0) 0 (0) 0 (0) 8 (62) 2 (15) 1 (8) 2 (15) 13 
E. coli 1 (2) 2 (4) 3 (6) 12 (22) 10 (19) 4 (7) 21 (40) 53 
Alpha Streptococcus 8 (5) 8 (5) 10 (6) 72 (43) 17 (10) 11 (6) 41 (25) 167 
U. urealyticum 0 (0) 0 (0) 5 (24) 6 (28) 0 (0) 5 (24) 5 (24) 21 
Staphylococcus sp. 1 (3) 3 (7) 2 (5) 14 (35) 6 (15) 3 (7) 11 (28) 40 
Propionibacterium sp. 0 (0) 0 (0) 0 (0) 2 (100) 0 (0) 0 (0) 0 (0) 2 
Actinomyces sp. 0 (0) 0 (0) 0 (0) 1 (50) 0 (0) 0 (0) 1 (50) 2 
Corynebacterium sp. 0 (0) 1 (4) 0 (0) 13 (54) 3 (13) 1 (4) 6 (25) 24 
Staphylococcus aureus 1 (3) 3 (7) 2 (5) 14 (35) 6 (15) 3 (7) 11 (28) 40 
Streptococcus Group B 33 (3) 50 (4) 107 (9) 547 (43) 148 (12) 66 (5) 306 (24) 1,257 
Streptococcus Group D 9 (4) 14 (7) 22 (11) 56 (27) 33 (16) 34 (17) 38 (18) 206 
 
2.4.4 Enrichment of Biological Functions and Pathways Among the Differentially 
Methylated Gene Sets 
We further analyzed whether these differentially methylated probes in the placenta were 
enriched for four specific biological functions: inflammation, growth/transcription factors, 
transport, and/or immune response, selected for their known critical functions for fetal 
development. For this analysis, the unique genes that corresponded with differentially 
methylated probes were considered (n=1,080). A Yates corrected 2 test was used in conjunction 
with a right-tailed Fisher Exact test (=0.05) to determine that immune-related proteins (n=50, 
p=0.000075), transcription/growth factors (n=134, p=0.00173), and inflammatory response 
(n=35, p=1.27E-09) were enriched amogst the CpG sites demonstrating differential methylation 
associated with bacterial presence (Supplemental Table 1).  
Among the 50 immune-related genes, Nuclear Factor Kappa-light-chain-enhancer of 
activated B Cells (NF-B) signaling was the top canonical pathway (p=5.98E-05) 
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(Supplemental Table 1). Five of the immune-related genes are involved in NF-B signaling 
including two kinases, Bone Morphogenetic Protein Receptor Type 1A (BMPR1A) and Protein 
Kinase C Zeta (PRKCZ), two enzymes, TNF Alpha Induced Protein 3 (TNFAIP3) and Ubiquitin 
Conjugating Enzyme E2 N (UBE2N), and one transmembrane receptor, Insulin Like Growth 
Factor 1 Receptor (IGF1R). The CpG probes corresponding to these five genes were all 
hypomethylated. All five of the genes had at least one of their hypomethylated probes altered 
when Streptococcus Group B bacteria was present in the placenta. Alpha-hemolytic 
Streptococcus was associated with a hypomethylated probe for BMPR1A and PRKCZ while 
IGF1R had probes altered with the presence of P. bivia. Based on the transcription factor 
occupancy theory, which is a proposed mechanism of genome-wide patterning of DNA 
methylation [68], we identified the transcription factors of the immune-related genes that were 
enriched. The top five transcription factors were: Tripartite Motif Containing 24 (TRIM24) 
(p=7.27E-05), RELA Proto-Oncogene NF-B Subunit (RELA) (p=2.54E-04), Tumor Protein P53 
(TP53) (p=3.18E-04), Core-binding Factor Beta Subunit (CBFB) (p=6.58E-04), and POU Class 
5 Homeobox 1 (POU5F1) (p=7.82E-04) (Supplemental Table 2).  
2.5 Discussion 
The presence of microorganisms in the placenta has been associated with inflammation 
and negative birth outcomes, including preterm birth [7]. Intriguing data from mouse studies and 
cell culture suggest that bacteria in the placenta can alter CpG methylation [21, 24]. To evaluate 
whether the presence of microorganisms is associated with the human placental epigenome, we 
integrated data for 16 different microbial species in the placenta with genome-wide CpG 
methylation levels. A total of 1,789 probes, representing 1,079 genes, were identified that were 
differentially methylated (q<0.1) in relation to placental bacteria. Interestingly, each bacteria 
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type corresponded with a distinct CpG methylation pattern within the placenta. The genes that 
corresponded to the differentially methylated probes were enriched for their roles as 
growth/transcription factors, immune response proteins, and inflammatory response proteins and 
are active in the NF-B pathway. Interestingly, the NF-B pathway is critical during pregnancy 
and for fetal development [191, 192]. Overall, our findings demonstrate that the presence of 
microorganisms in the placenta is associated with differences in CpG methylation. The specific 
genes with altered methylation could represent etiologic factors that contribute to placental 
function and fetal health.  
 The data from the study show that 14 of the bacteria species were associated with unique 
CpG probes, with not much overlap between the bacterial types. The three Streptococcus sp. 
displayed the most differentially methylated CpG probes. The presence of Streptococcus Group 
B was associated with the most differentially methylated probes, corresponding to 802 genes. 
Streptococcus Group D and -Streptococcus followed with 206 probes (112 genes) and 167 
probes (105 genes), respectively. Propionibacterium sp. was the most prevalent bacteria present 
in 10 placentas. The majority of the differentially methylated probes for each placental 
bacterium, were hypomethylated, meaning they displayed decreased methylation levels at a 
specific probe in relation to microbes. The fact that there is little overlap between the CpG 
probes that are differentially methylated for each bacterium shows a diverse placental epigenetic 
response depending on which bacterial species is present.  
 In the present analysis, the NF-B pathway was enriched among the microorganism-
associated differentially methylated genes. The NF-B pathway is a pro-inflammatory signaling 
pathway that is activated by pathogens or stressors [193]. It has been shown that bacterial 
plasmid DNA activates a signaling cascade that leads to activation of the NF-B pathway and 
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expression of inflammatory genes [194]. There is also accumulating evidence that NF-B 
activity increases with the onset of labour [73, 74] and is tied to children’s health later in life 
[18]. Of the five NF-B genes that were differentially methylated, four are known to induce NF-
B signaling. For example, UBE2N plays a role in activating the NF-B pathway [195] and  
PRKCZ is a component of the TNF/IL1 pathway that controls activation of the NF-B pathway 
[196-198] and induces contraction of myometrial tissue during late pregnancy [199].  TNFAIP3 
is the only differentially methylated gene that inhibits NF-B activation [200, 201]. All probes 
associated with the five NF-B genes were hypomethylated, with at least one of the probes being 
altered in the presence of Streptococcus Group B. While there are exceptions, hypomethylation 
of CpG sites often leads to the upregulation of genes [64]. From this evidence, we conclude that 
the presence of microorganisms in the placenta, especially Streptococcus Group B, is likely 
associated with activation of the NF-B pathway. These findings are in agreement with the 
positive association between anaerobic Streptococcus and systemic inflammation in the 
ELGANs in early life, where these bacteria were associated with increased levels of five out of 
16 tested inflammatory proteins that are upregulated by NF-κB activation including, IL-1β, IL-6, 
TNFR1, TNFR2, and E-selectin [23].  
 The transcription factor occupancy theory proposes that transcription factors are drivers 
of gene-specific DNA methylation patterns [68]. The transcription factor binding either prevents 
or allows the DNA methylation machinery access to the DNA sequence and therefore this 
binding influences gene-specific methylation. Thus, to test this theory, an analysis was carried 
out to identify the enriched transcription factors of the immune-related genes. One of the 
enriched transcription factors was NF-B p65 (RelA), a transcriptional activator of the NF-B 
pathway. Six of our 50 immune-related genes are transcribed by RelA and the CpG probes that 
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are associated with these genes were all hypomethylated in the presence of Streptococcus Group 
B bacteria. RelA is involved in the expression of IL-8, which is a chemokine that mediates an 
inflammatory response. An increase in IL-8 has been associated with premature labor [202]. 
RelA has also been identified as a key regulator of the cytokine environment that is required for 
a successful pregnancy. The suppression of RelA is critical for the shift towards Th2-type 
immune responses during pregnancy [203, 204]. POU5F1 was associated with all 
hypomethylated genes and is of interest because it plays a crucial role in embryonic development 
and stem cell pluripotency [205]. These enriched transcription facts may influence CpG 
methylation in the placenta as well as pregnancy outcomes and fetal development.  
 There are multiple factors that should be considered when interpreting the results from 
this study. The sample size was relatively small (n=84) and bacteria prevalence was low. 
Nevertheless, 52% of the placentas in the study harbored at least one type of bacteria, which is 
similar to a prior study of 1,083 placentas in the ELGAN cohort that found 79% and 43% of 
preterm placentas at 23 weeks and 27 weeks, respectively, carried microorganisms [154]. It is 
important to note that the data on microbial presence represent live, functional bacteria detected 
as colony forming units rather than simply DNA, which may be derived from dead or non-
functional microorganisms. While differential methylation of CpG sites in placentas with 
microorganisms was identified, gene expression was not a part of the analysis. As a proxy for 
gene expression data the placental methylome data was integrated into existing genomics 
datasets to establish the functional epigenetics and biological pathways. Future research would 
benefit from a larger sample size and should incorporate mRNA and protein expression data 
along with the CpG methylation data.  
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 This study is among the first to investigate the potential effect of placental bacteria on the 
methylome of the placenta. While outside the scope of the current study, future analysis could 
examine the molecular mechanism underlying microbe-CpG methylation, which could include 
altered DNA methyltransferase activity [69, 206, 207]. A major observation from the current 
study is that the CpG methylation patterning differs depending on microorganism presence in the 
placenta. These differences might be associated with variation in fetal development, birth 
outcomes and later life disease of premature babies. The genes corresponding to the differentially 
methylated probes in this study are associated with immune and inflammatory responses, 
especially the NF-B pathway.    
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CHAPTER 3: INFLAMMAMATORY GENE EXPRESSION IN THE PLACENTA IN 
THE PRESENCE OF MICROORGANISMS AND NEUROCOGNITIVE OUTCOMES 
AT AGE 10 IN PRETERM CHILDREN 
3.1 Overview 
Children born preterm, before 37 weeks, exhibit impairments in a variety of different 
domains including motor and executive function, social cognition, and language and mathematic 
ability [132, 134, 138-143]. This impairment may persist as the child ages resulting in poor 
performance in school [133, 134]. The survivability of preterm children continues to increase, 
leading to the potential for more children to live with neurological deficits [146, 147]. However, 
neither the etiology nor the underlying biological mechanism of this neurocognitive impairment 
in preterm children is understood. 
  The developmental origins of health and disease (DOHaD) hypothesis proposes that 
prenatal exposures can affect health outcomes later in life [1, 2], including neurocognitive 
outcomes [3, 4]. In support of the DOHaD hypothesis, bacterial infection of the intrauterine 
environment (e.g. the placenta) has been associated with neurological outcomes [117-119, 164]. 
The presence of microorganisms in the placenta has been shown to induce the production of pro-
inflammatory proteins in both cell culture and mouse model studies [21, 22, 61, 208]. In 
addition, within the Extremely Low Gestational Age Newborn (ELGAN) cohort, certain 
microbes in the placenta have been associated with epigenetic modifications, that may alter 
expression of genes involved in the pro-inflammatory nuclear factor kappa-light-chain-enhancer 
of activated B cell (NF-B) pathway [72]. However, gene expression was not assessed, a gap 
that this study will address.   
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Inflammation of the placenta and other fetal membranes due to bacterial infection has 
also been associated with brain injury in newborns [120] as well as neurological disorders later 
in life, such as cerebral palsy and autism spectrum disorder [26, 27, 107, 120]. As a potential 
mechanism to explain this association, there is evidence that inflammatory signals are 
transmitted from maternal to fetal tissues through the placenta [94] and that maternal 
inflammation can lead to elevated levels of pro-inflammatory proteins in the fetal circulation [9]. 
Once present in fetal blood, cytokines and other inflammation-related proteins cause damage to 
the developing fetal brain [9, 16-18, 20, 91-93].  
3.2 Study Objectives 
Previous research within the ELGAN cohort identified an association between the 
presence of culturable placental microorganisms and an increase in expression of inflammation-
related proteins in newborns blood [23]. In other ELGAN studies, this increase of inflammatory-
proteins in newborn blood was associated with an increased risk of neurological impairment at 
ages two and ten [29-32]. In the present study, we set out to test the hypothesis that 
microorganisms are associated with an inflammatory genomic response in the placenta and 
examine if placental inflammation affects later life neurocognitive outcomes. To do this, we 
assessed messenger RNA (mRNA) expression levels of inflammation-related genes in the 
placenta in relation to placental microorganisms. In addition, we determined whether the 
differential expression of any of the inflammatory genes is associated with neurocognitive 
function at 10 years of age.  
3.3 Materials and Methods 
3.3.1 Study Subject Recruitment and Participation 
The ELGAN study recruitment process occurred between 2002 and 2004 at 14 different 
ELGAN research sites in the United States [151]. Briefly, women who gave birth before 28 
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weeks gestational age at one of the research sites were asked to participate in the study. All 
procedures were approved by the Institutional Review Boards at each of the 14 study sites. 
Informed, written consent was provided within a few days of delivery. The mother’s consent 
covered both her and her child’s participation in the study.  
A total of 1,506 mother/infant pairs enrolled in the study of which 1,365 placentas were 
collected and assessed for microorganisms. Follow-ups were conducted when the children 
reached 2 years of age and again at 10 years of age. At the 2-year follow-up 1,102 children were 
enrolled and evaluated [151]. At the 10-year follow-up 889 children participated in a 
neurological assessment. Of these children, 807 had their placenta parenchyma cultured and 
analyzed for microorganisms and 425 of those were assessed for inflammation.     
3.3.2 Demographic and Pregnancy Variables  
Following delivery, each mother was interviewed by a trained research nurse interviewed 
using a structured data collection form. The mother’s report of her own characteristics and 
exposures, as well as the sequence of events leading to preterm delivery were taken as truth, even 
when her medical record provided discrepant information. 
Shortly after the mother’s discharge, the research nurse reviewed the maternal chart using 
a second structured data collection form. The medical record was relied on for events following 
admission. The clinical circumstances that led to preterm delivery were operationally defined 
using both data from the maternal interview and data abstracted from the medical record [152]. 
Each mother/infant pair was assigned to the category that described the primary reason for 
preterm delivery.    
3.3.3 Placenta Sample Collection 
As a part of the ELGAN study mothers were asked to provide their placentas for analysis. 
Delivered placentas were placed in a sterile exam basin and transported to a sampling room. 
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Placentas were biopsied at the midpoint of the longest distance between the cord insertion and 
the edge of the placental disk. The amnion was pulled back to expose the chorion using sterile 
technique. Traction was applied to the chorion and a piece of the underlying trophoblast tissue 
was removed. The tissue sample was placed into a cryo-vial and immersed in liquid nitrogen 
immediately. Specimens were stored at minus 80°C for approximately 15 years until processing 
[154]. 
3.3.4 Bacterial Analysis of placenta 
 The placentas were assessed for microorganisms as described [154]. A portion of each 
placenta sample was separated using a sterile scalpel and homogenized in a phosphate buffered 
saline solution (PBS). Serial dilutions of the homogenate were made in PBS and aliquots of the 
original homogenate and the dilutions were plated onto selective and nonselective bacteriologic 
media, which included: pre-reduced Brucella base agar, tryptic soy agar, chocolate agar, and A-7 
agar. Following incubation the various colony types were enumerated, isolated, and identified at 
the Brigham and Women’s Microbiology Laboratory using estimated criteria [155]. Since we 
have determined the constituents of the chorion parenchyma in the ELGANs prevent the reliable 
detection of bacterial DNA by PCR techniques, this study assessed only placental colonization 
patterns obtained by culture techniques. 
3.3.5 RNA Extraction and Assessment of Inflammation-Related Gene Expression  
 A small subsample of placental tissue, about 0.2 grams, was cut from the frozen sample 
and rinsed with 1x PBS to remove any residual blood. Samples were then homogenized in 
Qiagen Buffer RLT (Qiagen, Valencia CA). The extraction was completed with Qiagen’s 
Allprep Universal DNA/RNA/miRNA kit, and was automated using Qiagen’s QIAcube sample 
prep robotic workstation. This method captures RNA sequences that are greater than 18 
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nucleotides in length. Total mRNA was quantified using the NanoDrop 2000C (Thermo Fisher 
Scientific, Waltham, MA) and quality was assessed using TapeStation.   
 A total of 50 ng of mRNA extracted from each placental sample was evaluated for 
comparative expression of 249 inflammation-related genes using nCounter Human Inflammation 
Panel (NanoString Technologies, Inc., Seattle, WA). This panel was selected because our 
previous research indicated that inflammatory genes were differentially methylated in the 
presence of microorganisms and we wanted to explore whether this methylation altered gene 
expression [72]. This panel also includes six housekeeping genes, eight negative controls, and 
four positive controls. Nanostring’s nCounter technology employs direct digital detection of 
mRNA molecules of interest which allows for a high-throughput, sensitive, and accurate 
measurement of gene expression from small quantities of mRNA that does not require 
amplification [209].  
 Raw expression data were extracted using the nSolver software (NanoString 
Technologies, Inc., Seattle, WA). Background correction was conducted to eliminate false 
positives using the geometric mean of the negative control probes [210]. Out of the 249 genes in 
the panel, 72 were not detectable above baseline, leaving 177 for analysis. The mRNA data were 
normalized in a two-step process as per the manufacturer’s specifications [210]. First, positive 
control normalization was carried out to account for platform-associated sources of variation 
followed by housekeeping gene normalization to account for variability in mRNA input [210]. 
3.3.6 Procedures for the Neurocognitive Assessments at 10-years of Age 
 All families who participated in the 2-year follow up were contacted and invited to 
participate in the 10-year follow up. Families that agreed to participated were scheduled for a 
three to four hour visit during which all of the assessments were administered. During the child’s 
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assessment, the parent/caregiver completed questionnaires regarding the child’s medical status 
and neurological behavior. 
3.3.6.1 Cognitive Function Derived from Latent Profile Analysis (LPA) 
 This outcome variable has been described elsewhere. [156]. Briefly, it was derived from 
latent profile analysis of data from nine intelligence and executive function variables. IQ was 
assessed with the School-Age Differential Ability Scales-II (DAS-II) Verbal and Nonverbal 
Reasoning scales [157]. Executive function included two subtests from DAS-II, DAS Recall of 
Digits Backward and Recall of Sequential Order, which measured verbal working memory [157], 
and five subtests from the NEPSY-II (A Developmental NEuroPSYchological Assessment-II) 
[158]. The NEPSY-II Auditory Attention and Response Set measured auditory attention, set 
switching and inhibition, the NEPSY-II Inhibition and Inhibition Switching measured simple 
inhibition and inhibition in the context of set shifting, respectively, and the NEPSY-II Animal 
Sorting measured visual concept formation and set shifting. The LPA identified four subgroups 
of study participants with similar profiles: normal, low-normal, moderately impaired, and 
severely impaired. 
3.3.6.2 Oral and Written Language Scales (OWLS) Oral Composite  
 The Oral and Written Language Scales (OWLS) evaluated expressive and receptive 
language skills [159]. The OWLS oral composite score includes both listening comprehension 
and oral expression. To allow for differences in age at the times of assessment and to facilitate a 
comparison of our findings to those reported for children presumably born very near term we 
used Z-scores based on distributions of values reported for the historical normative samples that 
are described [159].  
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3.3.6.3 Academic Function  
 The Wechsler Individual Achievement Test-III (WIAT-III) provides standard scores in 
word recognition and numeric operations [160]. For these tests, we again used Z-scores based on 
distributions of values reported for the historical normative samples [160]. 
3.3.7 Data Analyses  
3.3.7.1 Microorganisms in Relation to Gene Expression 
 In order to determine whether placental microorganisms are associated with gene 
expression of inflammation-related genes, Analysis of Covariance (ANCOVA) was performed. 
There were 15 bacterial species or groups assessed including: Lactobacillus sp., Prevotella bivia, 
Gardnerella vaginalis, anaerobic Streptococcus, Peptostreptococcus sp., Escherichia coli, alpha-
hemolytic Streptococcus, Ureaplasma urealyticum, Mycoplasma sp., Staphylococcus sp., 
Propionibacterium sp., Actinomyces sp., Corynebacterium sp., Streptococcus Group B, and 
Streptococcus Group D. Each model examined whether the presence of an individual bacterial 
species or bacterial type was associated with differential expression of the 177 inflammation-
related genes.  Models were adjusted based on several dichotomous variables including fetal-sex, 
maternal race, whether the mother took an antibiotic during pregnancy, whether the mother 
experienced a vaginal infection during pregnancy, whether the mother experienced a urinary 
tract infection (UTI) during pregnancy, and whether the birth occurred via C-section. Bacterial 
species were considered to be significantly associated with gene expression if p-value <0.05 and 
the false discovery rate-corrected p-value <0.1 for any given gene. Data analysis was carried out 
using Partek Genomic Suites 6.6. 
3.3.7.2 Gene Expression in Relation to 10-Year Outcomes 
 In order to determine whether the expression of inflammatory-related genes are 
associated with neurocognitive function at age 10, separate logistic regression models were 
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performed for the genes found to be significant in relation to placental microorganisms. Each 
model examined whether the expression of an inflammation-related gene was associated with 
increased odds of scoring one or more standard deviations below the normative mean on three 
different assessments: OWLS Oral Language Composite, WIAT-III Word Recognition, and 
WIAT-III Numerical Operations. In the case of LPA, the models examined whether the 
expression of inflammation-related genes was associated with increased odds of having moderate 
to severe cognitive impairment. Confounders included in the models were the same as in the 
previous analysis plus maternal education. These models yielded odds ratios (ORs) and 95% 
confidence intervals (CI) of each 10-year characteristic associated with inflammation-related 
genes. Genes were considered to be significantly associated with a neurological function if p-
value <0.05 and the OR 95% CI did not include one.   
3.4 Results 
3.4.1 Study Subject Characteristics  
 The mRNA expression levels of inflammation-related genes were assessed within the 
placentas of 425 of the 889 ELGAN subjects that participated in the 10-year follow-up 
assessment. These 425 individuals make up our subcohort for this study. The subcohort is similar 
to the overall 10-year cohort as is demonstrated in Table 7. Within the subcohort there are 
slightly more males, 223 (52.5%), than females, 202 (47.5%). Most of the children were 
delivered by C-section (67%). The majority of mothers received between 12 and 16 years of 
education (49%) while 53 (13%) completed high school or less and 154 (36%) completed college 
or higher. The majority of the women did not have a vaginal infection (81%) or UTI (84%) 
during pregnancy and 128 (30%) took an antibiotic while they were pregnant. There are not 
results for each of the four assessments for every single child within our subcohort. However, 
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there was a very high participation rate ranging from 97% for the OWLS oral composite scores 
up to 100% for the LPA.  
Table 7. Demographics  
 Overall 10-year 





Fetal Sex   
Male 455 (51.2) 223 (52.5) 
Female 434 (48.8) 202 (47.5) 
Maternal Race   
White 557 (62.7) 261 (61.4) 
Non-white 319 (35.9) 159 (37.4) 
NS 13 (1.5) 5 (1.2) 
Maternal Education, years   
 12 (high school) 126 (14.2) 53 (12.5) 
Some college or 
Associates Degree 
431(48.5) 206 (48.5) 
College or higher 306 (34.4) 154 (36.2) 
NS 26 (2.9) 12 (2.8) 
Delivery Method   
C-section 590 (66.4) 283 (66.6) 
Natural 299 (33.6) 142 (33.4) 
UTI   
No 747 (84.0) 358 (84.2) 
Yes 119 (13.4) 56 (13.2) 
NS 23 (2.6) 11 (2.6) 
Vaginal Infection   
No 740 (83.2) 345 (81.2) 
Yes 126 (14.2) 69 (16.2) 
NS 23 (2.6) 11 (2.6) 
Antibiotic Use   
No 602 (67.7) 285 (67.1) 
Yes 263 (29.6) 128 (30.1) 
NS 24 (2.7) 12 (2.8) 
LPA    
Yes 874 (98.3) 425 (100) 
No 15 (1.7) 0 (0) 
OWLS oral composite   
Yes 849 (95.5) 411 (96.7) 
No 40 (4.5) 14 (3.3) 
WIAT-III word recognition   
Yes 864 (97.2) 420 (98.8) 
No 25 (2.8) 5 (1.2) 
WIAT-III numerical operations   
Yes 874 (98.3) 424 (99.8) 
No 15 (1.7) 1 (0.2) 
NS = Not specified  
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 The most common bacteria present in the study placentas was Staphylococcus sp. which 
was detected in 55 (12.9%) placentas (Table 8). The least prevalent bacterial species were 
anaerobic Streptococcus and Streptococcus Group B, which were present in 16 (3.8%) placentas. 
The rest of the bacterial species were found in between 17 (4.0%), in the case of G. vaginalis, 
and 34 (8.0%), in the case of Corynebacterium sp., placentas. This includes alpha-hemolytic 
Streptococcus which was detected in 28 (6.6%). 
Table 8. Presence of microorganisms in the placenta 
Bacteria n (%) 
Lactobacillus sp. 32 (7.5) 
P. bivia 18 (4.2) 
G. vaginalis 17 (4.0) 
Anaerobic Streptococcus 16 (3.8) 
Peptostreptococcus sp. 20 (4.7) 
E. coli 23 (5.4) 
Alpha Streptococcus 28 (6.6) 
U. urealyticum 21 (4.9) 
Mycoplasma sp. 23 (5.4) 
Propionibacterium sp. 32 (7.5) 
Actinomyces sp. 24 (5.6) 
Corynebacterium sp. 34 (8.0) 
Staphylococcus sp.  55 (12.9) 
Streptococcus Group B 16 (3.8) 
Streptococcus Group D 21 (4.9) 
 
3.4.2 Identification of Differentially Expressed Inflammation-Related Genes in Placentas 
Exposed to Bacteria   
 The differential expression of 177 inflammation-related genes in placentas were analyzed 
within the ELGAN cohort between 425 individuals with or without placental microbes. 
Statistical significance was adjusted using false discovery rate-corrected p-values (q<0.1). A 
total of 31 out of the 177 genes displayed significantly differential expression between placentas 
that harbored bacteria and placentas that did not (Figure 7).  Of the 15 microbial species, three 
were associated with differentially expressed genes. Alpha-hemolytic Streptococcus was 
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associated with the upregulation of two genes, Cysteinyl Leukotriene Receptor 2 (CYSLTR2) and 
Transforming Growth Factor Beta 3 (TGFB3). Staphylococcus sp. was associated with increased 
expression of three genes, Complement C4A (C4A), G Protein Subunit Gamma Transducin 1 
(GNGT1), and Interleukin 4 (IL4). Streptococcus Group B was associated with the upregulation 
of 28 inflammation-related genes, including TGFB3, C4A, C-C Motif Chemokine Ligand (CCL) 
2, and CCL4 (Supplemental Table 3). 
 
Figure 7. Heatmap of differentially expressed genes corresponding to the placental 
microorganisms. The heatmap displays the 31 differentially expressed genes in relation to three 





3.4.3 Association of Neurocognitive Function at Age 10 in Relation to Inflammation-
Related Gene Expression 
 To test whether inflammation-related genes that were differentially expressed in the 
presence of bacteria were associated with neurocognitive outcomes, we ran logistic regression 
models. Interestingly, out of the 31 genes that were differentially expressed in relation to 
microorganisms none of them were associated with statistically significant differential odds on 
any of the four neurocognitive assessments (p<0.05, data not shown). 
3.5 Discussion 
In this study, we set out to explore two associations. The first was whether 
microorganisms in the placental were associated with an inflammatory genomic response. The 
second was to determine whether the expression of any of the inflammatory-related genes were 
associated with 10-year neurocognitive outcomes. We show that the presence of alpha-hemolytic 
Streptococcus, Staphylococcus sp., and Streptococcus Group B in the placenta of children born 
extremely preterm were associated with increased expression of 31 inflammation-related genes 
in placental tissue. While these genes displayed bacterial-associated changes in expression, there 
was no association between placental inflammatory gene expression and neurocognitive function 
at 10 years of age. These data indicate that certain bacterial species in the placenta are associated 
with an inflammatory response but that this response in the placenta is not associated with 
neurocognitive function at age 10.  
The presence of Streptococcus Group B was associated with the increased expression of 
28 inflammatory genes. Our previous work showed hypomethylation of inflammation-related 
genes in placentas that harbored Streptococcus Group B [72]. While there are some exceptions, 
hypomethylation within gene promoters often leads to upregulation of the gene, thus in line with 
the findings from this study [64]. Streptococcus Group B is found in the lower genital tract and is 
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the leading cause of early onset sepsis and meningitis in newborns [211, 212]. When present in 
the placenta it is associated with preterm birth and histologic chorioamnionitis, inflammation of 
the placenta and other fetal membranes [213]. In addition, Staphylococcus sp. and alpha-
hemolytic Streptococcus were only associated with increased expression of three and two genes 
respectively. Staphylococcus sp. and alpha-hemolytic Streptococcus are not as common of 
intrauterine infections as Streptococcus Group B, and therefore have not been studied as 
thoroughly. However, there is evidence of an association with both Streptococcus sp. and 
Streptococcus Group B and chorioamnionitis [214, 215].  
  In the present study, a total of 31 unique genes were upregulated in the presence of a 
specific microorganism. Many of these genes have been associated with pregnancy 
complications, such as chorioamnionitis and preeclampsia, including TGFB3, C4A, Major 
Histocompatibility Complex, Class II, DR Beta 1 (HLA-DRB1), C-X-C Motif Chemokine Ligand 
(CXCL) 1, CXCL2, and Cluster of Differentiation 163 (CD163) [190, 216-221]. In support of our 
results, a separate study showed that chorioamnionitis induced by Group B Streptococcus was 
associated with increased expression of CXCL1 [222]. CXCL1 is of interest because it is essential 
for neural cell development [223-225]. Providing further support for the data presented here, in a 
rat model, chorioamnionitis was associated with increased expression of CXCL1 in the placenta, 
neonatal blood, and the developing brain, as well as brain injury [220].  CCL2, another gene that 
was upregulated in the presence of Group B Streptococcus, is known to have receptors in the 
placenta as well as the embryonic brain [226-228]. CCL2 plays a role in the development of 
hypothalamic neurons that control behavior [229].  
While previous research has shown an association between placental inflammation and 
neurological outcomes [26, 120], this is the first study to measure the mRNA expression of 
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inflammatory-related genes. The expression of individual inflammation-related genes in the 
placenta that were upregulated in the presence of bacteria were not associated with 
neurocognitive outcomes in 10 year olds. This could be because assays of delivered placentas 
may not reflect the gene expression occurring at critical points of development in vivo [230]. 
Also, these analyses focused on a targeted set (n=31) of genes. While these genes were selected 
for their role in inflammation in the presence of bacterial species, other genes with important 
relationships to children’s cognition could be captured in the future using a genome-wide 
approach. Importantly, even though inflammation of the placental tissue was not associated with 
later life health outcomes, it is important to note that inflammation in newborn blood has been. 
For example, CCL4, which was upregulated in the placentas with Streptococcus Group B in this 
study, was also upregulated in the blood of newborns whose placentas harbored 
Peptostreptococcus sp. or U. urealyticum [23]. Increased expression of CCL4 in newborn blood 
was associated with developmental delays at age 2 in another ELGAN study [28]. The data from 
the current study highlight the role of inflammatory processes in the placenta as responders to 
microbial presence.  
This study is among the first to assess mRNA expression of pro-inflammatory genes in 
the placenta in relation to a variety of bacterial species as well as neurocognitive function at 10-
years of age. Our data should be interpreted with several limitations in mind. There was a 
relatively low prevalence of each bacterial species, limiting the power to detect associations. 
Nevertheless, 209 (49%) of the placentas in this study harbored at least one type of culturable 
microorganism, which is consistent with previous findings [46]. While based upon a specific 
hypothesis focus, another limitation could be that a limited number of genes were assessed. 
Future research could use a genome-wide approach to identify genes outside of this set that may 
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be associated with placental bacterial presence and later life neurocognitive function. Strengths 
of this study include the large sample size, the broad range of neurocognitive assessments, and 
the breadth of data from the placenta at birth to the child 10 years later.  
In summary, there were two major findings from this study. First, the presence of a few 
different microorganisms in the placenta was associated with increased expression of 
inflammation-related genes in individuals born extremely preterm. Second, the expression of the 
inflammation-related genes in the placenta was not associated with neurocognitive function at 
age 10. This study helps inform our understanding of prenatal factors and placental function and 
their influence of neurocognitive outcomes later in life.
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CHAPTER 4: DISSERTATION DISCUSSION, CONCLUSIONS, AND FUTURE 
DIRECTIONS 
Collectively, the studies presented as a part of my dissertation demonstrate that culturable 
microorganisms in the placenta are associated with altered placental function, through variations 
in DNA CpG methylation and/or gene expression in the placenta, and are associated with 
neurocognitive function at 10 years of age. Specifically, in Chapter 1 we demonstrated that the 
presence of specific bacterial species in the placenta are associated with neurocognitive function 
at age 10. In Chapter 2, we found that microorganisms in the placenta are associated with unique 
CpG methylation profiles of the placenta. In Chapter 3 we demonstrated that specific placental 
microorganisms are associated with the altered expression of inflammatory-associated genes. 
These data provide a potential mechanistic understanding for processes involved in prenatal 
exposure to bacteria and long term neurocognitive outcomes.  
A primary goal of the work in Chapter 1 was to identify microorganisms in the placenta 
that were associated with neurocognitive and social-communicative function at age 10 (Figure 
8). The hypothesis was that microorganisms in the placenta are associated with differential 
performance and brain function of school-age children, with a variable response depending on 
bacterial species. This is based on previous research that found associations between placental 
infection and neurodevelopmental outcomes [129] as well as brain damage in the newborns 
[131]. In our research, the presence of U. urealyticum, alpha-hemolytic Streptococcus, 
Corynebacterium sp., G. vaginalis, and Staphylococcus sp. were associated with increased risk 
of learning limitations at age 10. A proposed mechanism underlying this relationship is that 
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microorganisms trigger inflammatory responses in the placenta [21, 22] that may impact the 
development of the fetal brain [19]. This research is important as it is the first study to identify 
specific microbial species, as opposed to indicators of infection, in relation to later-life 
neurological function. In contrast to the majority of the microorganisms, Lactobacillus sp. 
presence was associated with a decreased risk of neurocognitive function. This is likely due to its 
anti-inflammatory effect [23, 174, 175]. In addition, we found no association between any of the 
placental microorganisms and social-communicative function. Taken together, this study 
identified specific bacterial species in the placenta that are associated with a variety of 
neurocognitive functions at 10 years of age.  
 A major goal of the work in Chapter 2 was to investigate the role of bacteria in the 
placenta on the placental CpG methylome (Figure 8). The hypothesis was that the presence of 
microorganisms in the placenta would be associated with altered CpG methylation of 
development-associated genes. This was based on studies that found differential methylation in 
other tissue types as well as the murine placenta in the presence of bacterial organisms [24, 69, 
70]. This study identified that bacteria in the placenta are associated with differential methylation 
of 1,789 CpG probes. Furthermore, each bacterial type corresponded with a unique and distinct 
pattern of CpG methylation. The presence of Streptococcus Group B was associated with the 
largest number of differentially methylated probes. Genes that corresponded to the differentially 
methylated probes are enriched for growth/transcription factors, immune-related proteins, and 
inflammation-related proteins. Specifically, among the inflammation-related genes we found an 
enrichment of the NF-B pathway. Interestingly, the NF-B pathway has been shown to be 
critical pathway for pregnancy and fetal development [18, 73, 74]. Two proposed mechanisms 
underlying the relationship between microorganisms in the placenta and CpG methylation 
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include the transcription factor occupancy theory [68] and a non-gene specific process in which 
bacterial presence induces the production of reactive oxygen species [65] which has been shown 
to modulate DNA CpG methylation [66].  Taken together, data from the second study 
demonstrate that the presence of microorganisms in the placenta is associated with altered 
placental CpG methylation. Furthermore, the results provide evidence of how altered CpG 
methylation could contribute to placental function as well as fetal health. 
 The research presented in Chapter 3 examined placental mRNA expression of 
inflammation-related genes in relation to microbial presence in the placenta (Figure 8) as well as 
10 year neurocognitive outcomes (Figure 8). The two-part hypothesis was that first, 
inflammatory-related genes will be overexpressed in placentas that contain pro-inflammatory 
microorganisms and second, children whose placentas had increased expression of 
inflammatory-related genes would be at a higher risk for negative neurocognitive outcomes at 
age 10. Given that in Chapter 2 inflammatory-related genes were differentially methylated in the 
presence of bacteria it seemed probable that expression of these genes would also be altered. A 
set of 31 inflammation-related genes were identified to be upregulated in the presence of three 
different microorganisms, Streptococcus Group B, Staphylococcus sp., and alpha-hemolytic 
Streptococcus. The presence of Streptococcus Group B was associated with 28 of the 31 
differentially expressed genes, which is consistent with the findings in the Chapter 2 (e.g. 
Streptococcus Group B displayed significant association with hypomethylation of inflammation-
related genes). It was surprising to find, however, that none of the differently expressed 
inflammation-related genes were associated with risk of neurocognitive function at age 10. This 
could be because gene expression in the placenta following labor may not reflect the in vivo gene 
expression that occurs earlier in pregnancy [230]. Also, it is possible that the mRNAs were 
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impacted by some degradation following delivery [230, 231]. Taken together, these data suggest 
that inflammation-related genes are over expressed in the presence of certain bacterial species, 
but, at least in the case of the placentas and the targeted genes under study here, mRNA 
expression of inflammation-related genes in the placenta was not associated with later-life 
neurocognitive function.   
 
Figure 8. Integrative schematic of associations between placental microorganisms, 
biological functions in the placenta, and later-life neurocognitive function. The arrows 
indicate the associations that were analyzed within the dissertation. Solid arrows represent 
associations that the findings support, while dashed arrows were associations that were 
hypothesized but not established through this research.  
In conclusion, these three studies demonstrate the associations among microorganisms in 
the placenta, CpG methylation and gene expression in the placenta and their association with 10-
year neurocognitive outcomes. These studies are among the first to examine a variety of different 
microbial species in the placenta and their effects on the placenta as well as later life 
neurological outcomes of the child. The conclusions from these studies inform the 
understandings of prenatal factors and their influence of neurocognitive function of children later 
in life.   
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4.1 The Presence of Placental Bacteria and their Impact on Placental Function and Later in 
Life Neurocognitive Function  
 In all three chapters, the presence of 15 different bacterial types and species in the 
placenta were analyzed within the ELGAN placenta. The presence of the individual bacteria was 
fairly consistent between the placentas studied in Chapter 1 (n=807 individuals), and those 
studied in Chapter 3 (n=425 individuals) (Table 9). In both of these studies, Staphylococcus sp. 
was the most prevalent bacteria, with its presence in 94 (12%) placentas in Chapter 1 and 55 
(13%) placentas in Chapter 3. This is consistent with the overall ELGAN cohort of 1,365 
placentas analyzed [178].  For the placentas studied in Chapter 2 (n=84 individuals), 
Propionibacterium sp. was the most prevalent bacteria (12%) and Mycoplasma sp. was the 
second most prevalent (11%). These differences may be due to the smaller sample size that was 
available for placentas with CpG methylation data in Chapter 2.  
Overall 51% of the ELGAN placentas analyzed were culture-positive for at least one of 
the 15 bacterial species [178]. This was consistent across all three of these studies. In Chapter 1 




Table 9. Bacterial presence in the placentas across all three studies  









Lactobacillus sp. 48 (5.9) 3 (3.6) 32 (7.5) 
P. bivia 41 (5.1) 3 (3.6) 18 (4.2) 
G. vaginalis 28 (3.5) 3 (3.6) 17 (4.0) 
Anaerobic Streptococcus 40 (5.0) 4 (4.8) 16 (3.8) 
Peptostreptococcus sp. 49 (6.1) 3 (3.6) 20 (4.7) 
E. coli 49 (6.1) 2 (2.4) 23 (5.4) 
Alpha-hemolytic Streptococcus  53 (6.6) 3 (3.6) 28 (6.6) 
U. urealyticum 43 (5.3) 5 (6.0) 21 (4.9) 
Mycoplasma sp. 42 (5.2) 9 (10.7) 23 (5.4) 
Propionibacterium sp. 55 (6.8) 10 (11.9) 32 (7.5) 
Actinomyces sp. 47 (5.8) 4 (4.8) 24 (5.6) 
Corynebacterium sp. 64 (7.9) 3 (3.6) 34 (8.0) 
Staphylococcus sp. 94 (11.6) 7 (8.3) 55 (12.9) 
Streptococcus Group B 38 (4.7) 2 (2.4) 16 (3.8) 
Streptococcus Group D 36 (4.5) 2 (2.4) 21 (4.9) 
 The majority of previous research on bacteria in the intrauterine environment has focused 
on microorganisms of vaginal origin or organisms associated with bacterial vaginosis such as U. 
urealyticum, Mycoplasma hominis, and G. vagninalis [36-38], which were all found within the 
study placentas. However, there was also a presence of skin and oral bacteria in the ELGAN 
placentas, including Streptococcus sp., Staphylococcus sp., Propionibacterium sp., and E. coli. It 
is hypothesized that these bacterial species translocate to the placenta through hematogenous 
transmission [52].   
In each of the chapters we compared the 15 microbial species analyzed in the ELGAN 
placentas to different placental factors or later life outcomes. In each study, the different bacterial 
types displayed various associations between the outcome of interest. Interestingly, two bacterial 
types, alpha-hemolytic Streptococcus and Staphylococcus sp., were significant across all three 
studies. In the first chapter, Staphylococcus sp. was associated with increased odds of deficits in 
math and language function while alpha-hemolytic Streptococcus was associated with increased 
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odds of deficits in mathematics. In the second chapter, alpha-hemolytic Streptococcus and 
Staphylococcus sp. were associated with 167 CpG probes corresponding to 105 genes and 40 
CpG probes corresponding to 22 genes, respectively. In the case of alpha-hemolytic 
Streptococcus the majority of the probes were hypomethylated in the presence of the bacteria, 
whereas the opposite was true for Staphylococcus sp. In Chapter 3, three bacterial species were 
associated with differential expression of inflammation-related genes in the placenta. Alpha-
hemolytic Streptococcus was associated with upregulation of two inflammation-related genes 
and Staphylococcus sp. was associated with upregulation of three genes. Streptococcus Group B 
was associated with the most differentially methylated CpG probes, 1,257 corresponding to 802 
genes, and the most differentially expressed inflammatory genes, 31 genes. However, 
Streptococcus Group B was not associated with any of the neurocognitive or social-
communicative outcomes analyzed in the first chapter.  
Interestingly, in the first chapter we found that the presence of Lactobacillus sp. was 
associated with decreased odds of neurocognitive deficits as measured by LPA in the child at age 
10. In all other cases the five bacteria, U. urealyticum, alpha-hemolytic Streptococcus, 
Corynebacterium sp., G. vaginalis, and Staphylococcus sp., were associated with increased odds 
of neurocognitive deficits. This could be explained by the fact that in other studies Lactobacillus 
sp. has produced a net anti-inflammatory effect [174, 175] and has been associated with a lower 
likelihood of systemic inflammation in the blood of newborns [23]. In Chapter 2 Lactobacillus 
sp. was associated with differential methylation of 44 genes corresponding to 32 genes. The 
majority, 77%, of them being hypomethylated. Lactobacillus sp. was not associated with 
differential expression of any of the 177 inflammation-related genes analyzed in Chapter 3. 
However, this was expected because there was no overlap between the genes analyzed in 
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Chapter 3 and the 32 genes differentially methylated in the presence of Lactobacillus sp. in 
Chapter 2.  
Taken together, the three studies show that about 49% of the ELGAN preterm placentas 
harbored at least one of the 15 microorganisms. In the ELGAN study, culture techniques were 
used to identify specific microorganisms in the placenta. However, other microbial species that 
were not analyzed for could be present and having an effect on the placenta as well as the 
developing fetus. Future research could include a microbiome assessment of the placenta in order 
to account for all microbial species present using a 16S rRNA gene sequencing approach.  We 
show that each bacterial type has a varying effect on neurocognitive outcomes at age 10, 
placental CpG methylation, and inflammation-related gene expression in the placenta.  
4.2 Assessment of mRNA Levels and CpG Methylation in Relation to Placental Microbes  
 In Chapter 2 we observed an enrichment among the differentially methylated genes for 
roles in inflammatory processes in the cell. This influenced our interest in the subsequent 
analysis of the mRNA expression of inflammation-related genes in the placenta using the 
NanoString nCounter Human Inflammation Panel in relation to placental bacteria. This panel 
included 249 inflammation-related genes, 10 of which were differentially methylated in relation 
to placental bacteria in Chapter 2. The ten genes that overlapped are C-C Motif Chemokine 
Receptor 3 (CCR3), CD4 Molecule (CD4), Histone Deacetylase 4 (HDAC4), Interferon 
Regulatory Factor 7 (IRF7), SHC Adaptor Protein 1 (SHC1), SMAD Family Member 7 
(SMAD7), Transforming Growth Factor Beta 3 (TGFB3), TNF Alpha Induced Protein 3 
(TNFAIP3), Toll Interacting Protein (TOLLIP), and Thymic Stromal Lymphopoietin (TSLP). 
These ten genes are associated with a total of 17 differentially methylated probes that were 
identified to display differential CpG methylation in the presence of four different bacteria 




Figure 9. Heatmap of differentially methylated CpG probes of genes analyzed for mRNA 
expression. The heatmap displays the 17 differentially methylated probes associated with the 10 
genes which were analyzed for expression in relation to placental microorganisms. The 17 
probes are along the y-axis. Red represents increased methylation and blue represents decreased 
methylation.  
Streptococcus Group B was associated with the hypomethylation of the probe associated 
with CCR3, CD4, IRF7, SHC1, SMAD7, TNFAIP3, and TOLLIP, two probes associated with 
TGFB3, and five probes associated with HDAC4. The presence of alpha-hemolytic 
Streptococcus is associated with hypomethylation of one of the HDAC4 probes and a TOLLIP 
probe. A different TOLLIP probe is also hypomethylated in the presence of P. bivia. Among 
these ten genes, only one had a probe that was hypermethylated in the presence of bacteria, TSLP 
in the presence of Staphylococcus sp. These data indicate that the presence of P. bivia, alpha-
hemolytic Streptococcus, and Streptococcus Group B in the placenta would likely be associated 
with an activated inflammatory-response since hypomethylation of a CpG site, in many cases, 
leads to upregulation of the gene [64].  
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 Of the 10 genes that showed differential CpG methylation in Chapter 2 and were 
analyzed for gene expression on the inflammation panel in Chapter 3, two demonstrated 
differential expression in the presence of bacteria (Figure 8). The two were TGFB3 and HDAC4 
in the presence of Streptococcus Group B. These probes were found to be hypomethylated in 
Chapter 2 and upregulated in Chapter 3 in the presence of Streptococcus Group B. Again, this is 
consistent with the theory that hypomethylation of CpG sites often leads to the upregulation of 
the genes [64]. Interestingly both TGFB3 and HDAC4 had multiple probes hypermethylated in 
the presence of Streptococcus Group B. While the other eight genes only had one probe 
differently methylated in the presence of bacteria. Since multiple CpG sites are associated with 
each gene it is logical that the more differentially methylated probes associated with a gene, the 
more likely there will be an alteration in gene expression.  
 In addition, of the four bacterial species that were associated with differential methylation 
of the inflammation-related genes analyzed for gene expression, three were associated with 
increased expression of inflammation-related genes, namely Streptococcus Group B, 
Staphylococcus sp., and alpha-hemolytic Streptococcus. The only bacteria that was not 
associated with differential expression of any of the inflammation-related genes was P. bivia. In 
the case of Streptococcus Group B, it was associated with differential CpG methylation of 1,080 
genes, 28 of which were related with the inflammatory response, and increased expression of 31 
inflammation-related genes. While Staphylococcus sp. and alpha-hemolytic Streptococcus did 
not have a direct overlap between differential methylation and differential expression of the same 
gene they still showed differential methylation and differential expression of inflammation-
related genes. In this case, differential methylation of one gene could lead to downstream effects 
and differential expression of a different inflammation-related gene.  
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Out of the 84 placentas were analyzed for CpG methylation, 79 of these placentas were 
assessed for expression of inflammation-related genes. Linear regression was used to compare 
the methylation beta differences of the 17 CpG probes to the expression of the 10 inflammation-
related genes that were associated with the probes in the 79 placentas. Out of the 17 CpG probes, 
11 of the probes exhibited a negative correlation between methylation and expression (Figure 
10). This finding is anticipated given that hypermethylation, or increased methylation, often 
leads to downregulation of a gene [64]. This was apparent in the probes associated with CD4, 
SHC1, SMAD7, TNFAIP3, TSLP, three of the five probes associated with HDAC4, both of the 
probes associated with TGFB3, and one of the probes associated with TOLLIP. The TOLLIP 
probe that exhibits this negative correlation with gene expression is the probe associated with 
Streptococcus Group B. The six other probes exhibit positive correlation when comparing 




Figure 10. Linear regression of CpG methylation of probes and mRNA expression of 
associated genes. The six plots represent a comparison of CpG methylation and expression of 
corresponding genes in 79 placentas from the ELGAN cohort. Gene expression is represented on 
the x-axis and the beta value, indicating CpG methylation, of each probe is represented along the 
y-axis. Each blue dot represents one placenta. The red line is the linear regression trend line of 




























































































































































 Overall, there is indication that CpG methylation of an individual probe is associated with 
altered expression of the corresponding gene (Figure 10). However, we also see that placentas 
that exhibited differential CpG methylation of genes enriched for the inflammatory response in 
the presence of microorganisms also had increased mRNA expression of inflammation-related 
genes when those same microorganisms were present, even when the specific inflammation-
related genes did not exhibit differential methylation. For example, when Streptococcus Group B 
was present in the placenta, Complement C2 (C2) was overexpressed, even though no probes 
associated with this gene were differentially methylated in the presence of Streptococcus Group 
B. Conversely, CCR3 was hypomethylated in placentas that harbored Streptococcus Group B but 
this inflammation-related gene was not differentially expressed.  This could be explained by the 
idea that differential CpG methylation of upstream regulators can lead to differential expression 
of genes downstream.  
4.3 Public Health Relevance 
 Globally, preterm birth is the leading cause of death in children under the age of five 
[232]. In the United States alone preterm birth occurs in half a million pregnancies every year 
[233]. Newborns that are born prematurely are at a higher risk of morbidity, mortality, and 
developmental problems throughout their lives, including neurocognitive delays [234]. Multiple 
factors contribute to preterm birth, including bacterial infection during pregnancy [7]. Recently 
the placenta, which connects the mother to the developing fetus and regulates the prenatal 
environment, has been shown to harbor microorganisms [10, 46]. However, there has been little 
research on how these microorganisms impact the placenta, its function, and the development of 
the fetus. Our research examines the relationship between microorganisms in the placenta and 
three different factors: neurocognitive function at age 10, placental CpG methylation, and 
 
78 
expression of inflammation-related genes in the placenta. Importantly, it reveals that each 
microbial species has varying effects on the placenta and the fetus.  
Our findings indicate that microorganisms in the placenta are associated with increased 
odds of decreased neurocognitive function at age 10, except when Lactobacillus sp. is present. 
Lactobacillus sp. has a protective effect on neurocognitive function as assessed by LPA score. 
While more research needs to be done, our findings indicate that Lactobacillus sp. could 
potentially be used as a way to counteract the effects of other bacterial species in mothers that 
have an intrauterine infection. Additionally, our findings indicate that the presence of 
Streptococcus Group B in the placenta leads to the most differentially expressed genes in the 
placenta as well as the strongest inflammatory response. While this inflammation was not 
associated with neurocognitive outcomes at 10 years of age, previous research has shown that 
inflammatory cytokines can damage the developing fetal brain [16-20].  
Streptococcus Group B is the leading cause of sepsis and meningitis in newborns [211, 
212] and its presence in the placenta leads to preterm birth and chorioamnionitis [213]. 
Currently, testing for Streptococcus Group B is part of routine prenatal care. However, this 
testing usually occurs between the 35th and 37th week of pregnancy. For babies that are born 
preterm they may not have had this testing. Also, these screenings only indicate whether 
Streptococcus Group B is present in the vagina. It does not indicate whether the bacteria have 
ascended into the intrauterine environment. Earlier screenings could indicate whether mothers 
are carriers of Streptococcus Group B and if they are susceptible to ascending infection. Given 
the impact that Streptococcus Group B has on the placenta, earlier treatment could be useful. 
Taken together these studies support the DOHaD hypothesis and provide evidence that prenatal 
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exposures, through epigenetic alterations in the placenta, can influence later life function of the 
child.  
4.4 Current Research as a Platform for Future Hypotheses Testing  
 Our research revealed the association between bacteria in the placenta, biological 
signaling pathways in the placenta, and child health later in life. Even though our findings 
contribute to understanding the underlying biological mechanisms that link placental infection 
and later-life neurocognitive function there are still gaps in the knowledge. For this reason, there 
are clear areas to target to improve the mechanistic understandings and public health relevance 
collected from this study. Our findings provide the basis for hypothesis generation and future 
research questions, include those detailed here.  
4.4.1 What Other Microorganisms are Present in Preterm Placentas and are they 
Associated with Neurocognitive Function at 10 Years of Age and Placental Cpg 
Methylation?   
Results from our study suggest that the presence of different bacterial types in the 
placenta have varying effects on placental CpG methylation, inflammation-related gene 
expression, and neurocognitive function at age 10. Given that our bacterial analysis used culture 
techniques to identify bacteria we were only able to identify targeted bacteria. Other bacterial 
species were likely present in the placenta and could have been contributing to placental 
alterations and later life outcomes. In our analysis, we also focused on individual bacteria types. 
However, in many of the placentas multiple bacteria were present. Examining the bacterial 
community as a whole might give more insight into and better understanding of how the bacteria 
are affecting the placenta and the developing fetus.      
One technique that would allow for this type of analysis is 16S rRNA gene sequencing   
A major strength of 16S rRNA gene sequencing is that it allows for the full microbiological 
diversity in a sample to be detected, even if species are of low-abundance [13].  This is possible 
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because the 16S rRNA gene is highly conserved across bacterial species while also allowing for 
differentiation between species [235].  One drawback of this method is that it cannot differentiate 
between living and dead bacteria [12]. The questions that could be tested would be the similar to 
those asked in Chapter 1 and 2: (1) are microorganisms in the placenta associated with 
differential performance and brain function of school-age children, with variable response 
depending on bacterial species?; (2) Is the presence of microorganisms in the placenta associated 
with altered CpG methylation of development-associated genes?  
Analyzing the placentas for bacterial presence using 16S rRNA gene sequencing would 
allow for the identification of the full microbial community present in the samples. With this 
information, we could run the same models that we ran in Chapter 1 and Chapter 2 and 
determine whether any other bacteria are associated with neurocognitive or social-
communicative function at age 10 or differential CpG methylation in the placenta.  
4.4.2 Is Genome-Wide Gene Expression Associated with Microorganisms in the Placenta 
and 10-Year Neurocognitive Outcomes?  
In Chapter 3 we used a targeted-gene approach to focus on inflammation-related genes 
and examine whether their expression was associated with placental microorganisms or 
neurocognitive outcomes later in life. While we found an association with microorganisms in the 
placenta there was no association with the specific genes we selected and neurocognitive 
outcomes. Future research could use a genome-wide approach to identify genes outside of the 
targeted set of 229 inflammation-related genes that may be associated with placental bacteria 
presence and later-life neurocognitive function. The question that could be tested is: Is mRNA 
expression of any genes associated with bacterial presence in the placenta and neurocognitive 
function at age 10?  
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This question could be assessed by analyzing the placentas using RNA sequencing 
(RNA-Seq), also known as whole transcriptome shotgun sequencing. Then, using the same 
statistical models used in Chapter 3, gene expression of all genes could be compared to the 
presence of placental bacteria and then subsequently to neurocognitive outcomes at 10-years of 
age. However, this would not address the limitation that mRNA may begin to degrade in the 
placenta following labor [230].     
4.4.3 Is CpG Methylation in the Placenta a Mediator or a Moderator of Placental Bacteria 
and Neurocognitive Function at Age 10?   
Our research demonstrated an association between microorganisms in the placenta and 
school-aged neurological function as well as differential placental CpG methylation. While we 
hypothesize that CpG methylation is an underlying biological mechanism, it is unknown whether 
placental bacteria directly affect CpG methylation in the placenta and whether this in turn affects 
neurocognitive function later in life. Support for this could be tested using a mediation analysis. 
The question that could be tested is: Does the methylation status of placental CpG sites act as a 
mediator of placental microorganisms and neurocognitive outcomes at age 10?  
The mediation analysis could be done using the existing data from the ELGAN cohort on 
placental microorganisms, CpG methylation in the placenta, and neurocognitive function at age 
10. However, analyzing more of the ELGAN placentas for methylation would help increase the 
statistical power. Examining whether CpG methylation is a mediator or moderator of the 
association between microorganisms in the placenta and neurological function later in life would 
allow for a better understanding of the underlying biological processes at work in the placenta 





In summary, a major contribution of this work is the finding that microorganisms in the 
placenta are associated with altered signaling pathways in the placenta as well as long term 
neurological outcomes in the child. This is demonstrated by associations between various 
placental microbes and neurocognitive function at age 10, differential methylation of CpG 
probes in placental tissue, and placental upregulation of inflammation-related gene. Collectively, 
these studies increase knowledge related to the potential mechanisms by which bacteria in the 
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Associated Canonical Pathways (P-values) 
-NF-B Signaling (5.98E-05) 
-Role of Osteoblases, 
Osteoclasts and Chondrocytes 
in Rheumatoid Arthritis 
(1.97E-04) 





-CCR5 Signaling in 
Macrophages (5.52E-04) 
-Molecular Mechanisms of 
Cancer (2.82E-13) 
-Human Embryonic Stem Cell 
Pluripotency (3.79E-13) 
-Role of Osteoblasts, 
Osteoclasts and Chondrocytes 
in Rheumatoid Arthritis 
(2.23E-11) 
-Axonal Guidance Signaling 
(7.02E-11) 

















APPENDIX 2: SUPPLEMENTAL TABLE 2 
Supplemental Table 2. Enriched transcription factors and associated genes from gene set 
Transcription Factor Associated Genes 
Tripartite Motif Containing 
24 (TRIM24) 
Tripartite Motif Containing 26 (TRIM26) 
Galectin 3 Binding Protein (LGALS3BP) 
Interferon Regulatory Factor 7 (IRF7) 
DExD/H-Box Helicase 60 (DDX60) 
 
RELA Proto-Oncogene,  
NF-B Subunit (RELA) 
Collagen Type IV Alpha 3 Binding Protein (COL4A3BP) 
Insulin Like Growth Factor 1 Receptor (IGF1R) 
Interferon Regulatory Factor 4 (IRF4) 
Interferon Regulatory Factor 7 (IRF7) 
ORAI Calcium Release-Activated Calcium Modulator 1 
(ORAI1) 
TNF Alpha Induced Protein 3 (TNFAIP3) 
 
Tumor Protein p53 (TP53) Rho/Rac Guanine Nucleotide Exchange Factor 2 (ARHGEF2) 
Colony Stimulating Factor 1 Receptor (CSF1R) 
Insulin Like Growth Factor 1 Receptor (IGF1R) 
Interleukin 4 Receptor (IL4R) 
Interferon Regulatory Factor 7 (IRF7) 
PRELI Domain Containing 1 (PRELID1) 
Protein Kinase C Zeta (PRKCZ) 
PYD and CARD Domain Containing (PYCARD) 
SMAD Family Member 6 (SMAD6) 
SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (SRC) 
Unc-5 Netrin Receptor B (UNC5B) 
 
Core-Binding Factor Beta 
Subunit (CBFB) 
CD4 Molecule (CD4) 
Colony Stimulating Factor 1 Receptor (CSF1R) 
Galectin 3 Binding Protein (LGALS3BP) 
 
POU Class 5 Homeobox 1 
(POU5F1) 
Bone Morphogenetic Protein Receptor Type 1A (BMPR1A) 
Insulin Like Growth Factor 1 Receptor (IGF1R) 
ORAI Calcium Release-Activated Calcium Modulator 1 
(ORAI1) 
PYD and CARD Domain Containing (PYCARD) 





APPENDIX 3: SUPPLEMENTAL TABLE 3 
Supplemental Table 3. Genes associated with placental microorganisms 
Bacteria Gene p-value q-value Fold Change 
Alpha-hemolytic 
Streptococcus 
CYSLTR2 0.002 0.075 3.88 
TGFB3 0.002 0.075 2.63 
Streptococcus Group 
B 
C1QA 0.031 0.046 2.25 
C1QB 0.002 0.014 3.28 
C1R 0.001 0.014 3.70 
C1S 0.004 0.015 2.83 
C2 0.044 0.049 2.23 
C4A 0.001 0.014 2.85 
CCL2 0.026 0.043 2.00 
CCL3 0.002 0.014 2.97 
CCL4 0.014 0.032 2.71 
CCL8 0.007 0.020 2.82 
CD163 0.038 0.046 2.48 
CFL1 0.042 0.049 2.10 
CXCL1 0.003 0.015 2.12 
CXCL2 0.009 0.025 2.35 
HDAC4 0.029 0.046 2.14 
HLA-DRA 0.038 0.046 3.32 
HLA-
DRB1 
0.005 0.015 3.70 
IL1A 0.050 0.053 1.87 
IL1R1 0.034 0.046 2.47 
MAP2K1 0.020 0.036 2.59 
MAP3K5 0.020 0.036 2.28 
MX2 0.038 0.046 2.64 
OAS2 0.004 0.015 3.36 
PDFGA 0.016 0.034 2.23 
PTGIR 0.032 0.046 1.84 
RELB 0.019 0.036 1.92 
STAT1 0.011 0.027 3.24 
TGFB3 0.002 0.014 3.078 
Staphylococcus sp. 
C4A 0.050 0.096 1.67 
GNGT1 0.026 0.096 1.84 
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